brain neoplasm: A neoplasm (disease) that involves the brain.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519870 |
1. Apply sex-specific ruleNone |
519870 |
2. Check conditionsNone |
519870 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
447 |
4. Check minimum number of eventsNone |
447 |
5. Include endpointsNone |
447 |
6. Filter based on genotype QC (FinnGen only) |
427 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D13
- Name in latin
- Neoplasma benignum oesophagi
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Oesophagus
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm of other and ill-defined parts of digestive system
- Benign neoplasms
- Neoplasms
- Any operation in hilmo
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2379 | 1167 | 1194 |
| Only index persons | 2084 | 1051 | 1033 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.03 | 0.03 |
| Only index persons | 0.04 | 0.04 | 0.04 |
| Median age at first event (years) | |||
| Whole population | 61.50 | 61.77 | 61.20 |
| Only index persons | 60.86 | 60.89 | 60.82 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 427 | 231 | 196 |
| Unadjusted period prevalence (%) | 0.09 | 0.08 | 0.09 |
| Median age at first event (years) | 61.66 | 59.79 | 63.86 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 447
- Matched controls
- 4470
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D13.0
ICD-10 Finland
Benign neoplasm: Oesophagus
+∞
307.7
435
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
15.7
162.5
361
941
D13.1
ICD-10 Finland
Benign neoplasm: Stomach
22.6
86.7
66
34
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
42.2
80.2
49
13
JDW98
NOMESCO Finland
Other transluminal endoscopic operation on stomach or duodenum
31.2
74.9
50
18
XJD02
NOMESCO Finland
Peroral endoscopic ultrasonography
27.4
57.5
40
16
JD1EE
NOMESCO Finland
Ultrasound examination of gastro-oesophageal reflux
255.7
45.9
46
*
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
11.3
44.8
49
48
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
5.1
44.5
113
278
UJD02
NOMESCO Finland
Gastroscopy
6.7
40.1
70
121
R13
ICD-10 Finland
Dysphagia
5.3
37.6
86
192
K22.7
ICD-10 Finland
Barrett oesophagus
12.2
32.2
33
29
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
4.6
31.5
85
216
JCA45
NOMESCO Finland
Endoscopic mucosal or submucosal resection in oesophagus
299.3
28.1
28
*
K22.1
ICD-10 Finland
Ulcer of oesophagus
9.8
26.8
32
35
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
4.0
26.7
89
264
A02BC05
ATC
esomeprazole; systemic
2.8
25.5
246
1353
UJF32
NOMESCO Finland
Coloscopy
2.8
23.7
173
817
UJC12
NOMESCO Finland
Flexible oesophagoscopy
29.1
22.5
30
11
R4190
NOMESCO Finland
Nutritional therapy
6.1
21.1
38
67
A02BC02
ATC
pantoprazole; systemic
3.1
20.1
362
2598
JCF12
NOMESCO Finland
Endoscopic insertion of prosthetic tube into oesphagus
20.4
18.4
27
14
A02BC01
ATC
omeprazole; systemic
2.4
17.1
165
867
JCC12
NOMESCO Finland
Thoracoscopic or laparoscopic partial oesophagectomy
49.4
16.1
19
*
C15.9
ICD-10 Finland
Malignant neoplasm: Oesophagus, unspecified
21.0
15.2
22
11
JC2AB
NOMESCO Finland
Oesophagus X-ray examination with contrast
13.1
15.1
26
21
WX002
NOMESCO Finland
Sedation and analgesia
2.5
14.9
118
562
JCA05
NOMESCO Finland
Endoscopic polypectomy in oesophagus
154.9
14.5
15
*
Z2221
NOMESCO Finland
Medical doctor
2.3
14.3
150
808
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
14.1
131
668
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.6
13.9
96
427
K22.2
ICD-10 Finland
Oesophageal obstruction
15.4
13.7
22
15
JN4BD
NOMESCO Finland
Extensive body CT
2.9
13.5
73
286
A02BC03
ATC
lansoprazole; oral
2.2
13.5
165
941
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
4.4
13.5
35
85
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.6
13.4
47
142
JDA05
NOMESCO Finland
Endoscopic polypectomy in stomach or pylorus
41.4
13.2
16
*
Z01.8
ICD-10 Finland
Other specified special examinations
2.3
12.8
128
670
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
12.6
101
480
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.1
12.6
185
1126
WX402
NOMESCO Finland
General anaesthesia
2.3
12.4
124
649
K92.1
ICD-10 Finland
Melaena
3.6
12.4
42
124
JCA55
NOMESCO Finland
Endoscopic dilatation of oesophagus
12.9
12.2
21
17
K21
ICD-10 Finland
Gastro-oesophageal reflux disease
3.5
12.1
43
131
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
3.5
12.1
43
131
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
12.0
251
1728
D64.9
ICD-10 Finland
Anaemia, unspecified
2.7
12.0
71
291
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.3
11.7
115
595
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.6
11.7
80
352
8140/3-C16.0
ICD-O-3
Adenocarcinoma, NOS, of cardia, NOS
66.7
11.7
13
*
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.2
11.2
115
605
JN4AD
NOMESCO Finland
Body CT examination
2.5
10.9
76
337
D13.9
ICD-10 Finland
Benign neoplasm: Ill-defined sites within the digestive system
61.5
10.7
12
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.1
10.6
133
755
K30
ICD-10 Finland
Functional dyspepsia
2.5
10.4
71
312
UJF30
NOMESCO Finland
Ileoscopy through colon
2.6
10.2
64
270
J45.1
ICD-10 Finland
Nonallergic asthma
3.0
10.2
48
174
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.4
9.8
37
117
C16.00
ICD-10 Finland
Cardia
56.2
9.7
11
*
A06AC01
ATC
ispaghula (psylla seeds); oral
2.0
9.5
143
862
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.1
9.5
106
574
JCA52
NOMESCO Finland
Other endoscopic procedure using diathermy or heat in oesophagus
+∞
9.4
9
*
N03AX16
ATC
[U] pregabalin
2.0
9.4
124
714
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.6
9.3
57
237
J45.9
ICD-10 Finland
Asthma, unspecified
2.1
9.3
104
562
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.7
9.2
52
208
K29.3
ICD-10 Finland
Chronic superficial gastritis
4.1
9.2
25
63
K90.0
ICD-10 Finland
Coeliac disease
4.1
8.7
24
61
JCA98
NOMESCO Finland
Other local endoscopic operation on oesophagus
51.0
8.7
10
*
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
3.5
8.6
30
90
JN3AD
NOMESCO Finland
Abdominal CT examination
2.3
8.6
75
366
JCA08
NOMESCO Finland
Endoscopic removal of foreign body from oesophagus
28.1
8.5
11
*
Z3231
NOMESCO Finland
Registered nurse
1.9
8.5
137
840
D13.3
ICD-10 Finland
Benign neoplasm: Other and unspecified parts of small intestine
20.5
8.5
12
6
WX004
NOMESCO Finland
Patient-controlled sedation
91.7
8.4
9
*
Z3226
NOMESCO Finland
Physiotherapist
2.1
8.4
97
529
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.9
8.4
138
851
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
2.8
8.3
43
164
WX600
NOMESCO Finland
Single shot through catheter
7.8
8.2
18
24
130
Kela drug reimbursment
Malignant tumour
2.4
8.0
56
248
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.4
7.9
60
276
UJC02
NOMESCO Finland
Rigid oesophagoscopy
11.1
7.8
14
13
K20
ICD-10 Finland
Oesophagitis
6.1
7.8
20
34
H02AB06
ATC
prednisolone; systemic
1.8
7.8
224
1629
WX882
NOMESCO Finland
High dependency care
4.5
7.8
19
44
K22.4
ICD-10 Finland
Dyskinesia of oesophagus
15.4
7.8
12
8
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.3
7.7
62
292
D13.2
ICD-10 Finland
Benign neoplasm: Duodenum
12.1
7.6
13
11
C15.4
ICD-10 Finland
Malignant neoplasm: Middle third of oesophagus
12.1
7.6
13
11
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
2.6
7.6
45
184
C15.3
ICD-10 Finland
Malignant neoplasm: Upper third of oesophagus
25.5
7.6
10
*
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
4.5
7.5
18
41
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
7.9
7.4
16
21
8140/3-C15.9
ICD-O-3
Adenocarcinoma, NOS, of esophagus, NOS
81.4
7.4
8
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.2
7.4
65
318
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
4.0
7.3
21
55
J02AC01
ATC
fluconazole; systemic
1.8
7.3
173
1183
ZXD10
NOMESCO Finland
Scheduled procedure
1.7
7.3
175
1202
JJ1CE
NOMESCO Finland
Liver, bile duct and pancreas endoscopic ultrasound examination
16.1
7.3
11
7
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
7.5
7.2
16
22
A02BA02
ATC
ranitidine; systemic
1.9
7.2
102
595
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.2
7.2
61
294
XJC02
NOMESCO Finland
Mesurement of oesophageal pressure and pressure profile of lower oesophageal sphincter
20.4
7.2
10
5
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.0
7.1
88
490
H02AB07
ATC
prednisone; oral
2.1
7.1
70
358
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
3.5
7.1
24
71
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
7.0
71
367
R06.0
ICD-10 Finland
Dyspnoea
1.8
6.9
140
914
A02BC04
ATC
rabeprazole; oral
2.4
6.8
50
226
R03BA01
ATC
beclometasone; inhalant
2.1
6.8
71
371
K22.8
ICD-10 Finland
Other specified diseases of oesophagus
40.7
6.8
8
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
3.2
6.7
27
89
R02
ICPC
Shortness of breath/dyspnoea
2.1
6.7
73
388
8070/3-C15.9
ICD-O-3
Squamous cell carcinoma, NOS, of esophagus, NOS
12.5
6.6
11
9
C03CA01
ATC
furosemide; systemic
1.7
6.5
155
1055
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.9
6.5
91
528
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
6.4
165
1146
K22.9
ICD-10 Finland
Disease of oesophagus, unspecified
14.6
6.4
10
7
E66.8
ICD-10 Finland
Other obesity
2.9
6.4
29
103
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.9
6.4
95
563
R53
ICD-10 Finland
Malaise and fatigue
1.8
6.4
123
789
D37.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Stomach
11.2
6.3
11
10
R4110
NOMESCO Finland
Physiotherapy
1.7
6.3
134
884
N06AX21
ATC
duloxetine; oral
2.1
6.2
61
312
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
7.8
6.2
13
17
K29.4
ICD-10 Finland
Chronic atrophic gastritis
4.2
6.1
16
39
J01MA02
ATC
ciprofloxacin; systemic
1.7
6.1
183
1319
TimeCodeWAS
↥TODO / Current known limitations:
- Only showing the top 300 codes, because showing all (sometimes 20k) makes the page too slow.
- Legend / how to read the glyphs.
- Show details (e.g. Fisher or Chi-square test, LR+, etc.) when clicking on a row.
- Explanation on the underlying data / how the TimeCodeWAS is done (e.g. matched cases / controls, eligibility).
- Download CSV.
- No filters and sorters.
- Limited amount of endpoints (~400) having TimeCodeWAS data.
- Cross-links to Risteys lab test pages for lab test codes.
OMOP concept
ln(OR)
%cases with code / %controls with code
2×2 table
Esophagoscopy, gastroscopy and duodenoscopy
UJD10 [2001304788]
UJD10 [2001304788]
1.3e+00
2.4e+00
3.2e+00
—
3.0e+00
2.9e+00
2.2e+00
cases:15.42%
controls:4.56%
cases:14.74%
controls:1.57%
cases:5.90%
controls:0.25%
—
—
cases:4.99%
controls:0.25%
cases:20.10%
controls:1.38%
cases:29.66%
controls:4.56%
68
201
373
4204
65
69
376
4336
26
11
415
4394
—
22
11
419
4389
84
60
334
4273
105
173
249
3624
Gastroenterology
10 [38004455]
10 [38004455]
1.3e+00
2.0e+00
2.9e+00
1.0e+50
3.3e+00
2.3e+00
1.7e+00
cases:15.65%
controls:5.04%
cases:14.74%
controls:2.34%
cases:7.48%
controls:0.43%
cases:33.33%
controls:0.00%
cases:12.02%
controls:0.52%
cases:19.86%
controls:2.38%
cases:27.40%
controls:6.43%
69
222
372
4183
65
103
376
4302
33
19
408
4386
147
0
294
4405
53
23
388
4377
83
103
335
4230
97
244
257
3553
Internal Medicine
11 [38004456]
11 [38004456]
6.0e-01
1.2e+00
1.8e+00
5.5e+00
1.7e+00
1.1e+00
8.1e-01
cases:35.15%
controls:22.91%
cases:26.98%
controls:9.63%
cases:7.48%
controls:1.32%
cases:21.54%
controls:0.11%
cases:7.71%
controls:1.43%
cases:23.68%
controls:9.42%
cases:37.29%
controls:20.96%
155
1009
286
3396
119
424
322
3981
33
58
408
4347
95
5
346
4400
34
63
407
4337
99
408
319
3925
132
796
222
3001
Outpatient Visit
OP [9202]
OP [9202]
5.8e-01
6.6e-01
1.0e+00
5.7e+00
1.5e+00
1.2e+00
1.1e+00
cases:82.31%
controls:72.28%
cases:69.39%
controls:53.89%
cases:25.85%
controls:11.37%
cases:66.21%
controls:0.66%
cases:40.59%
controls:12.70%
cases:78.47%
controls:52.80%
cases:91.81%
controls:79.35%
363
3184
78
1221
306
2374
135
2031
114
501
327
3904
292
29
149
4376
179
559
262
3841
328
2288
90
2045
325
3013
29
784
Thoracic and Cardiac Surgery
OMOP4822009 [45756830]
OMOP4822009 [45756830]
3.8e-01
1.4e+00
—
1.0e+50
3.9e+00
3.8e+00
2.4e+00
cases:2.72%
controls:1.88%
cases:3.17%
controls:0.77%
—
—
cases:4.76%
controls:0.00%
cases:7.03%
controls:0.16%
cases:12.20%
controls:0.32%
cases:11.58%
controls:1.21%
12
83
429
4322
14
34
427
4371
—
21
0
420
4405
31
7
410
4393
51
14
367
4319
41
46
313
3751
Stomach Pathology biopsy report
66114-0 [40768797]
66114-0 [40768797]
1.5e+00
2.5e+00
—
1.0e+50
2.9e+00
2.6e+00
1.8e+00
cases:8.62%
controls:2.02%
cases:9.30%
controls:0.84%
—
—
cases:19.05%
controls:0.00%
cases:2.72%
controls:0.16%
cases:10.29%
controls:0.85%
cases:12.71%
controls:2.42%
38
89
403
4316
41
37
400
4368
—
84
0
357
4405
12
7
429
4393
43
37
375
4296
45
92
309
3705
Neoplasm of uncertain or unknown behaviour: Other digestive organs
D37.7 [45552349]
D37.7 [45552349]
2.4e+00
2.9e+00
—
1.0e+50
—
3.3e+00
2.3e+00
cases:2.95%
controls:0.27%
cases:3.63%
controls:0.20%
—
—
cases:1.13%
controls:0.00%
—
—
cases:4.07%
controls:0.16%
cases:2.54%
controls:0.26%
13
12
428
4393
16
9
425
4396
—
5
0
436
4405
—
17
7
401
4326
9
10
345
3787
Upper gastrointestinal surgery
106 [44777669]
106 [44777669]
6.6e-01
1.2e+00
2.2e+00
—
2.7e+00
2.1e+00
1.3e+00
cases:17.23%
controls:9.69%
cases:13.38%
controls:4.52%
cases:6.58%
controls:0.77%
—
—
cases:11.56%
controls:0.84%
cases:25.36%
controls:4.02%
cases:31.07%
controls:10.64%
76
427
365
3978
59
199
382
4206
29
34
412
4371
—
51
37
390
4363
106
174
312
4159
110
404
244
3393
INR in Blood by Coagulation assay
34714-6 [3032080]
34714-6 [3032080]
4.8e-01
8.0e-01
1.7e+00
3.5e+00
1.4e+00
1.4e+00
7.0e-01
cases:15.19%
controls:9.97%
cases:13.38%
controls:6.52%
cases:11.56%
controls:2.25%
cases:3.63%
controls:0.11%
cases:9.52%
controls:2.43%
cases:20.81%
controls:5.89%
cases:26.55%
controls:15.22%
67
439
374
3966
59
287
382
4118
51
99
390
4306
16
5
425
4400
42
107
399
4293
87
255
331
4078
94
578
260
3219
ABO and Rh group [Type] in Blood by Confirmatory method
77397-8 [46236098]
77397-8 [46236098]
6.9e-01
1.1e+00
2.7e+00
1.0e+50
2.7e+00
1.8e+00
1.0e+00
cases:7.26%
controls:3.79%
cases:4.76%
controls:1.66%
cases:2.27%
controls:0.16%
cases:1.36%
controls:0.00%
cases:4.08%
controls:0.30%
cases:9.09%
controls:1.62%
cases:13.84%
controls:5.37%
32
167
409
4238
21
73
420
4332
10
7
431
4398
6
0
435
4405
18
13
423
4387
38
70
380
4263
49
204
305
3593
pantoprazole; oral, parenteral
A02BC02 [21600097]
A02BC02 [21600097]
6.0e-01
1.1e+00
1.1e+00
2.6e+00
1.8e+00
1.2e+00
7.1e-01
cases:29.71%
controls:18.89%
cases:27.21%
controls:10.74%
cases:7.26%
controls:2.66%
cases:2.49%
controls:0.18%
cases:12.93%
controls:2.39%
cases:30.62%
controls:11.29%
cases:37.29%
controls:22.70%
131
832
310
3573
120
473
321
3932
32
117
409
4288
11
8
430
4397
57
105
384
4295
128
489
290
3844
132
862
222
2935
esomeprazole; oral, parenteral
A02BC05 [21600100]
A02BC05 [21600100]
9.5e-01
1.5e+00
1.6e+00
—
1.9e+00
1.7e+00
1.3e+00
cases:21.09%
controls:9.35%
cases:18.14%
controls:4.72%
cases:5.90%
controls:1.25%
—
—
cases:7.48%
controls:1.18%
cases:21.05%
controls:4.80%
cases:26.55%
controls:9.11%
93
412
348
3993
80
208
361
4197
26
55
415
4350
—
33
52
408
4348
88
208
330
4125
94
346
260
3451
Oncology Clinic/Center
261QX0200X [38004268]
261QX0200X [38004268]
1.2e-01
8.7e-01
2.8e+00
1.0e+50
3.3e+00
1.5e+00
4.1e-01
cases:6.80%
controls:6.11%
cases:4.76%
controls:2.04%
cases:3.40%
controls:0.20%
cases:4.76%
controls:0.00%
cases:3.63%
controls:0.14%
cases:5.26%
controls:1.27%
cases:9.04%
controls:6.16%
30
269
411
4136
21
90
420
4315
15
9
426
4396
21
0
420
4405
16
6
425
4394
22
55
396
4278
32
234
322
3563
Dysphagia
R13 [45573013]
R13 [45573013]
2.8e-01
2.9e+00
3.1e+00
1.0e+50
—
2.5e+00
1.1e+00
cases:1.13%
controls:0.86%
cases:5.67%
controls:0.34%
cases:2.49%
controls:0.11%
cases:1.59%
controls:0.00%
—
—
cases:3.83%
controls:0.32%
cases:3.39%
controls:1.11%
5
38
436
4367
25
15
416
4390
11
5
430
4400
7
0
434
4405
—
16
14
402
4319
12
42
342
3755
Coeliac disease
K90.0 [45586745]
K90.0 [45586745]
1.9e+00
2.4e+00
—
—
—
2.5e+00
1.6e+00
cases:2.27%
controls:0.34%
cases:2.49%
controls:0.23%
—
—
—
—
—
—
cases:1.67%
controls:0.14%
cases:2.54%
controls:0.53%
10
15
431
4390
11
10
430
4395
—
—
—
7
6
411
4327
9
20
345
3777
Blood type and Crossmatch panel - Blood
34531-4 [3044640]
34531-4 [3044640]
5.7e-01
9.7e-01
2.3e+00
—
2.3e+00
1.8e+00
9.1e-01
cases:9.75%
controls:5.77%
cases:6.35%
controls:2.50%
cases:2.49%
controls:0.25%
—
—
cases:4.76%
controls:0.48%
cases:11.00%
controls:2.01%
cases:16.10%
controls:7.19%
43
254
398
4151
28
110
413
4295
11
11
430
4394
—
21
21
420
4379
46
87
372
4246
57
273
297
3524
Benign neoplasm: Stomach
D13.1 [45586087]
D13.1 [45586087]
2.8e+00
2.7e+00
1.0e+50
1.0e+50
1.0e+50
—
2.7e+00
cases:2.27%
controls:0.14%
cases:2.04%
controls:0.14%
cases:2.04%
controls:0.00%
cases:3.40%
controls:0.00%
cases:1.36%
controls:0.00%
—
—
cases:3.39%
controls:0.24%
10
6
431
4399
9
6
432
4399
9
0
432
4405
15
0
426
4405
6
0
435
4400
—
12
9
342
3788
Gastro-oesophageal reflux disease with oesophagitis
K21.0 [45543296]
K21.0 [45543296]
1.6e+00
2.3e+00
—
1.0e+50
—
2.9e+00
1.3e+00
cases:4.76%
controls:0.98%
cases:4.99%
controls:0.52%
—
—
cases:4.99%
controls:0.00%
—
—
cases:5.26%
controls:0.30%
cases:4.52%
controls:1.29%
21
43
420
4362
22
23
419
4382
—
22
0
419
4405
—
22
13
396
4320
16
49
338
3748
FEV1/FVC
19926-5 [3011505]
19926-5 [3011505]
1.3e+00
1.5e+00
—
—
2.5e+00
1.6e+00
1.3e+00
cases:7.03%
controls:2.11%
cases:3.40%
controls:0.82%
—
—
—
—
cases:1.59%
controls:0.14%
cases:3.59%
controls:0.74%
cases:4.80%
controls:1.42%
31
93
410
4312
15
36
426
4369
—
—
7
6
434
4394
15
32
403
4301
17
54
337
3743
Forced vital capacity [Volume] Respiratory system
19870-5 [3020158]
19870-5 [3020158]
1.3e+00
1.5e+00
—
—
2.5e+00
1.6e+00
1.3e+00
cases:7.03%
controls:2.11%
cases:3.40%
controls:0.82%
—
—
—
—
cases:1.59%
controls:0.14%
cases:3.59%
controls:0.74%
cases:4.80%
controls:1.42%
31
93
410
4312
15
36
426
4369
—
—
7
6
434
4394
15
32
403
4301
17
54
337
3743
FEV1
20150-9 [3024653]
20150-9 [3024653]
1.3e+00
1.5e+00
—
—
2.5e+00
1.6e+00
1.3e+00
cases:7.03%
controls:2.11%
cases:3.40%
controls:0.82%
—
—
—
—
cases:1.59%
controls:0.14%
cases:3.59%
controls:0.74%
cases:4.80%
controls:1.42%
31
93
410
4312
15
36
426
4369
—
—
7
6
434
4394
15
32
403
4301
17
54
337
3743
Supplier / Service Provider
OMOP5117446 [33004]
OMOP5117446 [33004]
-5.2e-01
-1.7e-01
6.4e-01
—
3.0e+00
2.7e+00
2.8e+00
cases:17.91%
controls:26.95%
cases:7.03%
controls:8.20%
cases:1.59%
controls:0.84%
—
—
cases:2.72%
controls:0.14%
cases:9.81%
controls:0.74%
cases:19.77%
controls:1.42%
79
1187
362
3218
31
361
410
4044
7
37
434
4368
—
12
6
429
4394
41
32
377
4301
70
54
284
3743
Amylase [Enzymatic activity/volume] in Serum or Plasma
1798-8 [3016771]
1798-8 [3016771]
6.4e-01
1.3e+00
2.1e+00
—
2.0e+00
1.3e+00
6.2e-01
cases:9.52%
controls:5.27%
cases:8.62%
controls:2.50%
cases:2.27%
controls:0.27%
—
—
cases:2.27%
controls:0.32%
cases:8.13%
controls:2.47%
cases:15.82%
controls:9.22%
42
232
399
4173
38
110
403
4295
10
12
431
4393
—
10
14
431
4386
34
107
384
4226
56
350
298
3447
Prealbumin [Mass/volume] in Serum or Plasma
14338-8 [3013742]
14338-8 [3013742]
6.9e-01
1.5e+00
—
—
2.8e+00
1.9e+00
1.7e+00
cases:2.95%
controls:1.50%
cases:3.40%
controls:0.82%
—
—
—
—
cases:2.27%
controls:0.14%
cases:5.26%
controls:0.83%
cases:9.32%
controls:1.87%
13
66
428
4339
15
36
426
4369
—
—
10
6
431
4394
22
36
396
4297
33
71
321
3726
Prothrombin time (PT) actual/Normal
5894-1 [3033658]
5894-1 [3033658]
3.7e-01
9.8e-01
2.2e+00
—
2.2e+00
1.5e+00
9.5e-01
cases:7.03%
controls:4.97%
cases:6.58%
controls:2.57%
cases:3.85%
controls:0.45%
—
—
cases:3.85%
controls:0.45%
cases:10.53%
controls:2.45%
cases:15.82%
controls:6.77%
31
219
410
4186
29
113
412
4292
17
20
424
4385
—
17
20
424
4380
44
106
374
4227
56
257
298
3540
Gastro-oesophageal reflux disease without oesophagitis
K21.9 [45538509]
K21.9 [45538509]
1.4e+00
1.9e+00
—
1.0e+50
—
2.6e+00
1.6e+00
cases:4.08%
controls:1.00%
cases:2.49%
controls:0.39%
—
—
cases:2.49%
controls:0.00%
—
—
cases:3.83%
controls:0.30%
cases:5.08%
controls:1.08%
18
44
423
4361
11
17
430
4388
—
11
0
430
4405
—
16
13
402
4320
18
41
336
3756
C reactive protein [Mass/volume] in Serum or Plasma
1988-5 [3020460]
1988-5 [3020460]
3.3e-01
7.5e-01
1.4e+00
2.8e+00
1.4e+00
7.9e-01
3.9e-01
cases:32.88%
controls:26.08%
cases:31.97%
controls:18.16%
cases:12.93%
controls:3.54%
cases:3.17%
controls:0.20%
cases:14.29%
controls:4.09%
cases:33.01%
controls:18.35%
cases:52.54%
controls:42.85%
145
1149
296
3256
141
800
300
3605
57
156
384
4249
14
9
427
4396
63
180
378
4220
138
795
280
3538
186
1627
168
2170
Diaphragmatic hernia without obstruction or gangrene
K44.9 [45533596]
K44.9 [45533596]
1.4e+00
2.2e+00
—
1.0e+50
—
2.4e+00
1.3e+00
cases:3.17%
controls:0.79%
cases:2.49%
controls:0.27%
—
—
cases:7.48%
controls:0.00%
—
—
cases:3.83%
controls:0.35%
cases:3.95%
controls:1.11%
14
35
427
4370
11
12
430
4393
—
33
0
408
4405
—
16
15
402
4318
14
42
340
3755
Albumin [Mass/volume] in Serum or Plasma
1751-7 [3024561]
1751-7 [3024561]
4.7e-01
7.4e-01
2.3e+00
—
2.0e+00
1.5e+00
9.0e-01
cases:12.47%
controls:8.15%
cases:10.20%
controls:5.15%
cases:6.80%
controls:0.73%
—
—
cases:6.80%
controls:1.02%
cases:19.86%
controls:5.40%
cases:29.10%
controls:14.35%
55
359
386
4046
45
227
396
4178
30
32
411
4373
—
30
45
411
4355
83
234
335
4099
103
545
251
3252
Laboratory Visit
OMOP4822461 [32036]
OMOP4822461 [32036]
1.3e-01
3.8e-01
1.1e+00
4.2e+00
9.7e-01
3.6e-01
9.9e-02
cases:41.04%
controls:37.84%
cases:46.71%
controls:37.46%
cases:30.61%
controls:12.30%
cases:26.76%
controls:0.54%
cases:27.44%
controls:12.55%
cases:49.04%
controls:40.06%
cases:63.28%
controls:60.94%
181
1667
260
2738
206
1650
235
2755
135
542
306
3863
118
24
323
4381
121
552
320
3848
205
1736
213
2597
224
2314
130
1483
Gastroscopy
UJD02 [2001304787]
UJD02 [2001304787]
2.3e+00
2.3e+00
—
1.0e+50
—
—
2.4e+00
cases:3.17%
controls:0.34%
cases:1.59%
controls:0.16%
—
—
cases:4.76%
controls:0.00%
—
—
—
—
cases:3.39%
controls:0.32%
14
15
427
4390
7
7
434
4398
—
21
0
420
4405
—
—
12
12
342
3785
Medical doctor
Z2221 [2001311556]
Z2221 [2001311556]
7.9e-01
1.3e+00
2.1e+00
1.0e+50
1.3e+00
1.5e+00
1.3e+00
cases:11.11%
controls:5.36%
cases:6.58%
controls:1.86%
cases:2.27%
controls:0.27%
cases:8.84%
controls:0.00%
cases:1.59%
controls:0.45%
cases:6.46%
controls:1.59%
cases:11.30%
controls:3.48%
49
236
392
4169
29
82
412
4323
10
12
431
4393
39
0
402
4405
7
20
434
4380
27
69
391
4264
40
132
314
3665
mesalazine; oral, rectal
A07EC02 [21600664]
A07EC02 [21600664]
1.1e+00
1.2e+00
—
—
2.0e+00
1.2e+00
1.3e+00
cases:2.95%
controls:1.00%
cases:2.72%
controls:0.82%
—
—
—
—
cases:1.81%
controls:0.25%
cases:2.87%
controls:0.85%
cases:3.67%
controls:1.08%
13
44
428
4361
12
36
429
4369
—
—
8
11
433
4389
12
37
406
4296
13
41
341
3756
One hour or less
ZXE00 [2001311394]
ZXE00 [2001311394]
5.8e-01
1.0e+00
—
1.0e+50
2.3e+00
1.7e+00
1.0e+00
cases:11.56%
controls:6.81%
cases:4.54%
controls:1.66%
—
—
cases:1.81%
controls:0.00%
cases:1.59%
controls:0.16%
cases:6.22%
controls:1.20%
cases:11.58%
controls:4.40%
51
300
390
4105
20
73
421
4332
—
8
0
433
4405
7
7
434
4393
26
52
392
4281
41
167
313
3630
Blood group antibody screen [Presence] in Serum or Plasma
890-4 [3001079]
890-4 [3001079]
4.6e-01
6.6e-01
2.3e+00
—
2.3e+00
1.4e+00
6.4e-01
cases:12.24%
controls:8.10%
cases:7.03%
controls:3.75%
cases:4.31%
controls:0.45%
—
—
cases:5.44%
controls:0.59%
cases:11.48%
controls:3.00%
cases:19.77%
controls:11.46%
54
357
387
4048
31
165
410
4240
19
20
422
4385
—
24
26
417
4374
48
130
370
4203
70
435
284
3362
Bilirubin.total [Moles/volume] in Serum or Plasma
14631-6 [3006140]
14631-6 [3006140]
5.0e-01
9.7e-01
1.8e+00
—
1.4e+00
1.2e+00
7.5e-01
cases:15.19%
controls:9.76%
cases:13.83%
controls:5.74%
cases:6.12%
controls:1.11%
—
—
cases:5.22%
controls:1.34%
cases:17.70%
controls:6.05%
cases:28.53%
controls:15.80%
67
430
374
3975
61
253
380
4152
27
49
414
4356
—
23
59
418
4341
74
262
344
4071
101
600
253
3197
Other and unspecified abdominal pain
R10.4 [45568113]
R10.4 [45568113]
7.0e-01
1.6e+00
2.3e+00
1.0e+50
2.1e+00
9.9e-01
9.4e-01
cases:9.98%
controls:5.20%
cases:7.03%
controls:1.52%
cases:1.59%
controls:0.16%
cases:1.13%
controls:0.00%
cases:1.13%
controls:0.14%
cases:4.55%
controls:1.73%
cases:12.99%
controls:5.50%
44
229
397
4176
31
67
410
4338
7
7
434
4398
5
0
436
4405
5
6
436
4394
19
75
399
4258
46
209
308
3588
Otolaryngology
4 [38004449]
4 [38004449]
5.0e-01
8.8e-01
1.6e+00
—
1.6e+00
1.1e+00
8.2e-01
cases:18.37%
controls:11.96%
cases:9.75%
controls:4.29%
cases:3.40%
controls:0.68%
—
—
cases:3.63%
controls:0.73%
cases:10.53%
controls:3.92%
cases:22.88%
controls:11.51%
81
527
360
3878
43
189
398
4216
15
30
426
4375
—
16
32
425
4368
44
170
374
4163
81
437
273
3360
Barrett oesophagus
K22.7 [45605924]
K22.7 [45605924]
2.9e+00
—
1.0e+50
1.0e+50
—
—
3.6e+00
cases:2.04%
controls:0.11%
—
—
cases:1.13%
controls:0.00%
cases:1.59%
controls:0.00%
—
—
—
—
cases:4.52%
controls:0.13%
9
5
432
4400
—
5
0
436
4405
7
0
434
4405
—
—
16
5
338
3792
CBC panel - Blood by Automated count
58410-2 [40761511]
58410-2 [40761511]
1.9e-01
4.3e-01
1.2e+00
3.4e+00
7.5e-01
6.9e-01
2.4e-01
cases:34.01%
controls:29.90%
cases:28.80%
controls:20.86%
cases:13.61%
controls:4.47%
cases:3.17%
controls:0.11%
cases:8.84%
controls:4.36%
cases:35.17%
controls:21.46%
cases:50.56%
controls:44.54%
150
1317
291
3088
127
919
314
3486
60
197
381
4208
14
5
427
4400
39
192
402
4208
147
930
271
3403
179
1691
175
2106
Benign neoplasm: Colon, unspecified
D12.6 [45576377]
D12.6 [45576377]
7.7e-01
2.0e+00
—
—
—
2.5e+00
1.9e+00
cases:1.36%
controls:0.64%
cases:1.59%
controls:0.23%
—
—
—
—
—
—
cases:1.67%
controls:0.14%
cases:3.95%
controls:0.63%
6
28
435
4377
7
10
434
4395
—
—
—
7
6
411
4327
14
24
340
3773
Glucose [Moles/volume] in Serum or Plasma
14749-6 [3013826]
14749-6 [3013826]
3.1e-01
5.9e-01
2.1e+00
—
1.9e+00
1.1e+00
5.2e-01
cases:14.29%
controls:10.87%
cases:10.88%
controls:6.33%
cases:4.99%
controls:0.64%
—
—
cases:5.67%
controls:0.93%
cases:16.27%
controls:6.05%
cases:29.10%
controls:19.62%
63
479
378
3926
48
279
393
4126
22
28
419
4377
—
25
41
416
4359
68
262
350
4071
103
745
251
3052
Phosphate [Moles/volume] in Serum or Plasma
14879-1 [3003458]
14879-1 [3003458]
4.9e-01
7.2e-01
1.9e+00
—
1.8e+00
1.6e+00
9.4e-01
cases:4.08%
controls:2.54%
cases:3.17%
controls:1.57%
cases:1.59%
controls:0.25%
—
—
cases:1.81%
controls:0.32%
cases:7.18%
controls:1.57%
cases:10.45%
controls:4.37%
18
112
423
4293
14
69
427
4336
7
11
434
4394
—
8
14
433
4386
30
68
388
4265
37
166
317
3631
Platelets [#/volume] in Blood
26515-7 [3007461]
26515-7 [3007461]
1.4e-01
5.1e-01
1.3e+00
2.8e+00
9.5e-01
5.7e-01
1.6e-01
cases:37.87%
controls:34.60%
cases:41.50%
controls:29.92%
cases:22.00%
controls:7.22%
cases:4.99%
controls:0.32%
cases:17.23%
controls:7.43%
cases:45.69%
controls:32.22%
cases:60.17%
controls:56.25%
167
1524
274
2881
183
1318
258
3087
97
318
344
4087
22
14
419
4391
76
327
365
4073
191
1396
227
2937
213
2136
141
1661
Hematocrit [Volume Fraction] of Blood by calculation
20570-8 [3009542]
20570-8 [3009542]
1.4e-01
5.0e-01
1.3e+00
2.8e+00
9.7e-01
5.7e-01
1.6e-01
cases:37.87%
controls:34.69%
cases:41.50%
controls:30.17%
cases:22.00%
controls:7.26%
cases:4.99%
controls:0.32%
cases:17.46%
controls:7.43%
cases:45.69%
controls:32.29%
cases:60.17%
controls:56.36%
167
1528
274
2877
183
1329
258
3076
97
320
344
4085
22
14
419
4391
77
327
364
4073
191
1399
227
2934
213
2140
141
1657
Leukocytes [#/volume] in Blood
26464-8 [3010813]
26464-8 [3010813]
1.4e-01
5.1e-01
1.3e+00
2.8e+00
9.4e-01
5.7e-01
1.7e-01
cases:37.87%
controls:34.73%
cases:41.72%
controls:30.17%
cases:22.00%
controls:7.22%
cases:4.99%
controls:0.32%
cases:17.23%
controls:7.50%
cases:45.69%
controls:32.29%
cases:60.45%
controls:56.33%
167
1530
274
2875
184
1329
257
3076
97
318
344
4087
22
14
419
4391
76
330
365
4070
191
1399
227
2934
214
2139
140
1658
MCH [Entitic mass]
28539-5 [3035941]
28539-5 [3035941]
1.4e-01
5.0e-01
1.3e+00
2.8e+00
9.5e-01
5.7e-01
1.6e-01
cases:37.87%
controls:34.62%
cases:41.50%
controls:30.15%
cases:22.00%
controls:7.24%
cases:4.99%
controls:0.32%
cases:17.23%
controls:7.43%
cases:45.69%
controls:32.29%
cases:60.17%
controls:56.31%
167
1525
274
2880
183
1328
258
3077
97
319
344
4086
22
14
419
4391
76
327
365
4073
191
1399
227
2934
213
2138
141
1659
MCV [Entitic mean volume] in Red Blood Cells
30428-7 [3024731]
30428-7 [3024731]
1.4e-01
5.0e-01
1.3e+00
2.8e+00
9.5e-01
5.7e-01
1.6e-01
cases:37.87%
controls:34.69%
cases:41.50%
controls:30.17%
cases:22.00%
controls:7.24%
cases:4.99%
controls:0.32%
cases:17.23%
controls:7.43%
cases:45.69%
controls:32.33%
cases:60.17%
controls:56.33%
167
1528
274
2877
183
1329
258
3076
97
319
344
4086
22
14
419
4391
76
327
365
4073
191
1401
227
2932
213
2139
141
1658
Erythrocytes [#/volume] in Blood
26453-1 [3026361]
26453-1 [3026361]
1.4e-01
5.0e-01
1.3e+00
2.8e+00
9.5e-01
5.7e-01
1.6e-01
cases:37.87%
controls:34.71%
cases:41.50%
controls:30.17%
cases:22.00%
controls:7.24%
cases:4.99%
controls:0.32%
cases:17.23%
controls:7.43%
cases:45.69%
controls:32.33%
cases:60.17%
controls:56.36%
167
1529
274
2876
183
1329
258
3076
97
319
344
4086
22
14
419
4391
76
327
365
4073
191
1401
227
2932
213
2140
141
1657
Hemoglobin [Mass/volume] in Blood
718-7 [3000963]
718-7 [3000963]
1.4e-01
4.9e-01
1.3e+00
2.8e+00
9.5e-01
5.6e-01
1.5e-01
cases:38.10%
controls:34.76%
cases:41.50%
controls:30.19%
cases:22.00%
controls:7.24%
cases:4.99%
controls:0.32%
cases:17.23%
controls:7.48%
cases:45.69%
controls:32.36%
cases:60.17%
controls:56.41%
168
1531
273
2874
183
1330
258
3075
97
319
344
4086
22
14
419
4391
76
329
365
4071
191
1402
227
2931
213
2142
141
1655
General Surgery
2 [38004447]
2 [38004447]
3.8e-01
8.2e-01
1.2e+00
—
2.0e+00
1.1e+00
6.2e-01
cases:26.98%
controls:20.18%
cases:13.38%
controls:6.36%
cases:3.17%
controls:0.95%
—
—
cases:6.80%
controls:1.02%
cases:14.83%
controls:5.59%
cases:24.58%
controls:14.85%
119
889
322
3516
59
280
382
4125
14
42
427
4363
—
30
45
411
4355
62
242
356
4091
87
564
267
3233
Creatinine [Moles/volume] in Serum or Plasma
14682-9 [3020564]
14682-9 [3020564]
1.6e-01
4.5e-01
1.2e+00
2.8e+00
1.1e+00
5.5e-01
2.6e-01
cases:36.73%
controls:33.01%
cases:37.87%
controls:27.99%
cases:17.91%
controls:6.11%
cases:4.31%
controls:0.27%
cases:17.46%
controls:6.73%
cases:43.06%
controls:30.39%
cases:59.89%
controls:53.62%
162
1454
279
2951
167
1233
274
3172
79
269
362
4136
19
12
422
4393
77
296
364
4104
180
1317
238
3016
212
2036
142
1761
Nephrology
39 [38004479]
39 [38004479]
1.2e+00
1.3e+00
1.7e+00
—
2.2e+00
1.3e+00
1.2e+00
cases:3.40%
controls:1.07%
cases:3.63%
controls:0.98%
cases:1.59%
controls:0.30%
—
—
cases:2.04%
controls:0.23%
cases:3.11%
controls:0.83%
cases:3.39%
controls:1.08%
15
47
426
4358
16
43
425
4362
7
13
434
4392
—
9
10
432
4390
13
36
405
4297
12
41
342
3756
Sodium [Moles/volume] in Serum or Plasma
2951-2 [3019550]
2951-2 [3019550]
1.8e-01
4.4e-01
1.2e+00
2.8e+00
1.0e+00
5.6e-01
2.2e-01
cases:34.47%
controls:30.42%
cases:33.56%
controls:24.52%
cases:14.29%
controls:4.99%
cases:3.63%
controls:0.23%
cases:12.93%
controls:5.18%
cases:39.23%
controls:26.86%
cases:55.37%
controls:49.93%
152
1340
289
3065
148
1080
293
3325
63
220
378
4185
16
10
425
4395
57
228
384
4172
164
1164
254
3169
196
1896
158
1901
Potassium [Moles/volume] in Serum or Plasma
2823-3 [3023103]
2823-3 [3023103]
1.7e-01
4.3e-01
1.1e+00
2.8e+00
9.5e-01
5.6e-01
2.3e-01
cases:34.47%
controls:30.65%
cases:33.56%
controls:24.72%
cases:14.29%
controls:5.06%
cases:3.63%
controls:0.23%
cases:12.93%
controls:5.41%
cases:39.47%
controls:27.09%
cases:55.93%
controls:50.12%
152
1350
289
3055
148
1089
293
3316
63
223
378
4182
16
10
425
4395
57
238
384
4162
165
1174
253
3159
198
1903
156
1894
Outpatient Hospital
22 [8756]
22 [8756]
3.5e-01
8.7e-01
1.1e+00
—
1.7e+00
1.4e+00
8.0e-01
cases:35.83%
controls:28.26%
cases:17.01%
controls:7.92%
cases:3.17%
controls:1.07%
—
—
cases:5.90%
controls:1.18%
cases:20.33%
controls:6.00%
cases:33.33%
controls:18.41%
158
1245
283
3160
75
349
366
4056
14
47
427
4358
—
26
52
415
4348
85
260
333
4073
118
699
236
3098
General anaesthesia
WX402 [2001310806]
WX402 [2001310806]
6.5e-01
2.7e-01
2.0e+00
1.0e+50
2.6e+00
2.3e+00
9.2e-01
cases:3.17%
controls:1.68%
cases:1.36%
controls:1.04%
cases:1.13%
controls:0.16%
cases:1.59%
controls:0.00%
cases:2.04%
controls:0.16%
cases:7.42%
controls:0.83%
cases:9.32%
controls:3.95%
14
74
427
4331
6
46
435
4359
5
7
436
4398
7
0
434
4405
9
7
432
4393
31
36
387
4297
33
150
321
3647
Thorax X-ray examination
GD1AA [2001303617]
GD1AA [2001303617]
7.9e-01
7.0e-01
1.4e+00
1.0e+50
2.2e+00
1.3e+00
6.9e-01
cases:17.23%
controls:8.63%
cases:7.26%
controls:3.72%
cases:1.59%
controls:0.41%
cases:1.13%
controls:0.00%
cases:2.49%
controls:0.27%
cases:11.00%
controls:3.18%
cases:20.06%
controls:11.22%
76
380
365
4025
32
164
409
4241
7
18
434
4387
5
0
436
4405
11
12
430
4388
46
138
372
4195
71
426
283
3371
omeprazole; oral, parenteral
A02BC01 [21600096]
A02BC01 [21600096]
8.0e-01
1.2e+00
1.7e+00
—
1.3e+00
1.0e+00
9.4e-01
cases:10.20%
controls:4.88%
cases:6.80%
controls:2.09%
cases:2.27%
controls:0.41%
—
—
cases:1.81%
controls:0.52%
cases:5.74%
controls:2.17%
cases:8.47%
controls:3.50%
45
215
396
4190
30
92
411
4313
10
18
431
4387
—
8
23
433
4377
24
94
394
4239
30
133
324
3664
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M
62238-1 [40764999]
62238-1 [40764999]
1.5e-01
3.8e-01
1.3e+00
2.5e+00
1.2e+00
5.5e-01
2.2e-01
cases:24.94%
controls:22.22%
cases:25.85%
controls:19.23%
cases:12.70%
controls:3.93%
cases:2.72%
controls:0.23%
cases:13.83%
controls:4.75%
cases:30.62%
controls:20.24%
cases:44.92%
controls:39.48%
110
979
331
3426
114
847
327
3558
56
173
385
4232
12
10
429
4395
61
209
380
4191
128
877
290
3456
159
1499
195
2298
Thoracal epidural anesthesia
WX302 [2001310795]
WX302 [2001310795]
—
-1.0e+50
—
—
—
3.5e+00
1.9e+00
—
—
cases:0.00%
controls:0.20%
—
—
—
—
—
—
cases:3.83%
controls:0.12%
cases:2.82%
controls:0.42%
—
0
9
441
4396
—
—
—
16
5
402
4328
10
16
344
3781
Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
6768-6 [3035995]
6768-6 [3035995]
4.7e-01
9.2e-01
1.4e+00
—
1.2e+00
1.0e+00
4.8e-01
cases:25.62%
controls:17.71%
cases:24.94%
controls:11.65%
cases:8.62%
controls:2.34%
—
—
cases:7.71%
controls:2.55%
cases:27.75%
controls:12.28%
cases:40.68%
controls:29.71%
113
780
328
3625
110
513
331
3892
38
103
403
4302
—
34
112
407
4288
116
532
302
3801
144
1128
210
2669
Emergency Room Visit
ER [9203]
ER [9203]
4.3e-01
9.7e-01
1.5e+00
—
1.2e+00
6.8e-01
5.6e-01
cases:44.67%
controls:34.46%
cases:25.62%
controls:11.51%
cases:6.58%
controls:1.52%
—
—
cases:6.12%
controls:1.84%
cases:19.62%
controls:11.01%
cases:42.66%
controls:29.73%
197
1518
244
2887
113
507
328
3898
29
67
412
4338
—
27
81
414
4319
82
477
336
3856
151
1129
203
2668
Ulcer of oesophagus
K22.1 [45567295]
K22.1 [45567295]
2.5e+00
—
—
1.0e+50
—
—
2.9e+00
cases:2.27%
controls:0.18%
—
—
—
—
cases:1.81%
controls:0.00%
—
—
—
—
cases:3.11%
controls:0.18%
10
8
431
4397
—
—
8
0
433
4405
—
—
11
7
343
3790
Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
2039-6 [3003785]
2039-6 [3003785]
1.8e-01
8.5e-01
1.8e+00
—
2.1e+00
1.4e+00
6.5e-01
cases:2.27%
controls:1.91%
cases:3.17%
controls:1.38%
cases:1.81%
controls:0.30%
—
—
cases:2.27%
controls:0.27%
cases:5.26%
controls:1.32%
cases:4.80%
controls:2.55%
10
84
431
4321
14
61
427
4344
8
13
433
4392
—
10
12
431
4388
22
57
396
4276
17
97
337
3700
Inpatient Hospital
21 [8717]
21 [8717]
3.5e-01
7.7e-01
1.3e+00
—
1.2e+00
1.0e+00
6.9e-01
cases:41.50%
controls:33.28%
cases:21.09%
controls:10.96%
cases:5.90%
controls:1.61%
—
—
cases:6.12%
controls:1.98%
cases:22.73%
controls:9.35%
cases:38.14%
controls:23.65%
183
1466
258
2939
93
483
348
3922
26
71
415
4334
—
27
87
414
4313
95
405
323
3928
135
898
219
2899
MCHC [Entitic Mass/volume] in Red Blood Cells
28540-3 [3003338]
28540-3 [3003338]
6.8e-02
3.8e-01
1.2e+00
2.3e+00
1.0e+00
4.4e-01
7.4e-02
cases:26.53%
controls:25.22%
cases:27.66%
controls:20.70%
cases:14.06%
controls:4.61%
cases:2.95%
controls:0.30%
cases:11.79%
controls:4.70%
cases:30.86%
controls:22.27%
cases:44.07%
controls:42.24%
117
1111
324
3294
122
912
319
3493
62
203
379
4202
13
13
428
4392
52
207
389
4193
129
965
289
3368
156
1604
198
2193
Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1742-6 [3006923]
1742-6 [3006923]
2.0e-01
5.4e-01
1.0e+00
2.7e+00
6.8e-01
4.7e-01
2.3e-01
cases:35.15%
controls:30.83%
cases:35.37%
controls:24.27%
cases:10.88%
controls:4.15%
cases:1.59%
controls:0.11%
cases:9.30%
controls:4.95%
cases:36.60%
controls:26.56%
cases:57.63%
controls:51.88%
155
1358
286
3047
156
1069
285
3336
48
183
393
4222
7
5
434
4400
41
218
400
4182
153
1151
265
3182
204
1970
150
1827
Office Visit
OMOP4822458 [581477]
OMOP4822458 [581477]
5.9e-01
9.8e-01
1.5e+00
1.0e+50
1.7e+00
1.1e+00
9.8e-01
cases:15.42%
controls:9.22%
cases:7.26%
controls:2.86%
cases:1.59%
controls:0.36%
cases:2.27%
controls:0.00%
cases:2.49%
controls:0.48%
cases:7.66%
controls:2.61%
cases:15.54%
controls:6.45%
68
406
373
3999
32
126
409
4279
7
16
434
4389
10
0
431
4405
11
21
430
4379
32
113
386
4220
55
245
299
3552
FVC percent change Respiratory system
69982-7 [42868471]
69982-7 [42868471]
1.2e+00
1.5e+00
—
—
—
1.5e+00
1.2e+00
cases:6.35%
controls:2.02%
cases:2.95%
controls:0.68%
—
—
—
—
—
—
cases:2.63%
controls:0.62%
cases:4.24%
controls:1.34%
28
89
413
4316
13
30
428
4375
—
—
—
11
27
407
4306
15
51
339
3746
FEV1 --post bronchodilation
20155-8 [3023550]
20155-8 [3023550]
1.2e+00
1.5e+00
—
—
—
1.5e+00
1.2e+00
cases:6.35%
controls:2.02%
cases:2.95%
controls:0.68%
—
—
—
—
—
—
cases:2.63%
controls:0.62%
cases:4.24%
controls:1.34%
28
89
413
4316
13
30
428
4375
—
—
—
11
27
407
4306
15
51
339
3746
FEV1 percent change
69983-5 [42868472]
69983-5 [42868472]
1.2e+00
1.5e+00
—
—
—
1.5e+00
1.2e+00
cases:6.35%
controls:2.02%
cases:2.95%
controls:0.68%
—
—
—
—
—
—
cases:2.63%
controls:0.62%
cases:4.24%
controls:1.34%
28
89
413
4316
13
30
428
4375
—
—
—
11
27
407
4306
15
51
339
3746
FEV1/FVC --post bronchodilation
69970-2 [42868459]
69970-2 [42868459]
1.2e+00
1.5e+00
—
—
—
1.5e+00
1.2e+00
cases:6.35%
controls:2.02%
cases:2.95%
controls:0.68%
—
—
—
—
—
—
cases:2.63%
controls:0.62%
cases:4.24%
controls:1.34%
28
89
413
4316
13
30
428
4375
—
—
—
11
27
407
4306
15
51
339
3746
Forced vital capacity [Volume] Respiratory system --post bronchodilation
19875-4 [3001668]
19875-4 [3001668]
1.2e+00
1.5e+00
—
—
—
1.5e+00
1.2e+00
cases:6.35%
controls:2.02%
cases:2.95%
controls:0.68%
—
—
—
—
—
—
cases:2.63%
controls:0.62%
cases:4.24%
controls:1.34%
28
89
413
4316
13
30
428
4375
—
—
—
11
27
407
4306
15
51
339
3746
Pharmacy visit
OMOP4822462 [581458]
OMOP4822462 [581458]
3.7e-01
1.0e+00
8.0e-01
1.3e+00
9.9e-01
1.1e+00
7.6e-01
cases:95.69%
controls:93.89%
cases:94.56%
controls:85.97%
cases:69.16%
controls:50.19%
cases:8.62%
controls:2.57%
cases:71.88%
controls:48.82%
cases:95.45%
controls:87.21%
cases:97.74%
controls:95.29%
422
4136
19
269
417
3787
24
618
305
2211
136
2194
38
113
403
4292
317
2148
124
2252
399
3779
19
554
346
3618
8
179
metoclopramide; oral, parenteral, rectal
A03FA01 [21600484]
A03FA01 [21600484]
7.2e-01
8.8e-01
—
—
1.8e+00
1.9e+00
8.4e-01
cases:6.58%
controls:3.31%
cases:3.17%
controls:1.34%
—
—
—
—
cases:1.59%
controls:0.27%
cases:7.18%
controls:1.18%
cases:8.47%
controls:3.85%
29
146
412
4259
14
59
427
4346
—
—
7
12
434
4388
30
51
388
4282
30
146
324
3651
Bilirubin.conjugated [Moles/volume] in Serum or Plasma
29760-6 [3005772]
29760-6 [3005772]
8.6e-01
1.7e+00
—
—
—
1.5e+00
1.1e+00
cases:4.54%
controls:1.98%
cases:4.08%
controls:0.75%
—
—
—
—
—
—
cases:3.11%
controls:0.69%
cases:7.63%
controls:2.77%
20
87
421
4318
18
33
423
4372
—
—
—
13
30
405
4303
27
105
327
3692
Coloscopy
UJF32 [2001305029]
UJF32 [2001305029]
5.5e-01
1.1e+00
—
—
3.1e+00
9.1e-01
9.5e-01
cases:7.94%
controls:4.74%
cases:3.85%
controls:1.29%
—
—
—
—
cases:2.49%
controls:0.11%
cases:3.11%
controls:1.27%
cases:11.02%
controls:4.58%
35
209
406
4196
17
57
424
4348
—
—
11
5
430
4395
13
55
405
4278
39
174
315
3623
Anaemia, unspecified
D64.9 [45600610]
D64.9 [45600610]
1.1e+00
1.5e+00
2.5e+00
1.0e+50
—
9.6e-01
5.1e-01
cases:3.40%
controls:1.11%
cases:2.27%
controls:0.50%
cases:1.36%
controls:0.11%
cases:1.59%
controls:0.00%
—
—
cases:1.91%
controls:0.74%
cases:3.11%
controls:1.90%
15
49
426
4356
10
22
431
4383
6
5
435
4400
7
0
434
4405
—
8
32
410
4301
11
72
343
3725
Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2324-2 [3026910]
2324-2 [3026910]
4.3e-01
9.6e-01
1.7e+00
—
1.2e+00
7.8e-01
4.7e-01
cases:18.37%
controls:12.74%
cases:14.97%
controls:6.33%
cases:2.95%
controls:0.57%
—
—
cases:2.95%
controls:0.86%
cases:13.64%
controls:6.76%
cases:28.81%
controls:20.23%
81
561
360
3844
66
279
375
4126
13
25
428
4380
—
13
38
428
4362
57
293
361
4040
102
768
252
3029
Calprotectin [Mass/mass] in Stool
38445-3 [3048689]
38445-3 [3048689]
1.0e+00
1.9e+00
—
—
-1.0e+50
1.2e+00
9.8e-01
cases:4.31%
controls:1.59%
cases:4.99%
controls:0.82%
—
—
—
—
cases:0.00%
controls:0.16%
cases:3.11%
controls:0.92%
cases:7.63%
controls:3.00%
19
70
422
4335
22
36
419
4369
—
—
0
7
441
4393
13
40
405
4293
27
114
327
3683
Urea [Moles/volume] in Serum or Plasma
22664-7 [3020779]
22664-7 [3020779]
7.5e-01
9.3e-01
2.3e+00
—
1.8e+00
1.8e+00
9.7e-01
cases:3.17%
controls:1.52%
cases:2.49%
controls:1.00%
cases:1.81%
controls:0.18%
—
—
cases:1.36%
controls:0.23%
cases:5.98%
controls:1.04%
cases:6.78%
controls:2.69%
14
67
427
4338
11
44
430
4361
8
8
433
4397
—
6
10
435
4390
25
45
393
4288
24
102
330
3695
Extensive body CT
JN4BD [2001310899]
JN4BD [2001310899]
9.6e-02
1.6e+00
—
—
—
1.8e+00
1.5e+00
cases:2.49%
controls:2.27%
cases:3.17%
controls:0.64%
—
—
—
—
—
—
cases:3.11%
controls:0.53%
cases:3.67%
controls:0.82%
11
100
430
4305
14
28
427
4377
—
—
—
13
23
405
4310
13
31
341
3766
Paralysis of vocal cords and larynx
J38.0 [45543265]
J38.0 [45543265]
—
-1.0e+50
—
—
—
2.5e+00
2.4e+00
—
—
cases:0.00%
controls:0.11%
—
—
—
—
—
—
cases:1.44%
controls:0.12%
cases:1.98%
controls:0.18%
—
0
5
441
4400
—
—
—
6
5
412
4328
7
7
347
3790
Insertion of central venous catheter through external or internal jugular vein
TPH15 [2001309600]
TPH15 [2001309600]
1.1e+00
—
—
—
—
3.2e+00
1.6e+00
cases:1.81%
controls:0.59%
—
—
—
—
—
—
—
—
cases:2.87%
controls:0.12%
cases:3.67%
controls:0.76%
8
26
433
4379
—
—
—
—
12
5
406
4328
13
29
341
3768
Physiotherapy
R4110 [2001310233]
R4110 [2001310233]
4.5e-01
4.1e-01
1.7e+00
—
2.1e+00
1.8e+00
9.2e-01
cases:8.39%
controls:5.54%
cases:3.17%
controls:2.13%
cases:1.36%
controls:0.25%
—
—
cases:1.81%
controls:0.23%
cases:7.66%
controls:1.36%
cases:12.15%
controls:5.24%
37
244
404
4161
14
94
427
4311
6
11
435
4394
—
8
10
433
4390
32
59
386
4274
43
199
311
3598
Scheduled procedure
ZXD10 [2001311387]
ZXD10 [2001311387]
4.8e-01
8.6e-01
—
—
2.1e+00
1.7e+00
1.0e+00
cases:11.34%
controls:7.31%
cases:4.31%
controls:1.86%
—
—
—
—
cases:1.59%
controls:0.20%
cases:6.70%
controls:1.27%
cases:10.73%
controls:4.16%
50
322
391
4083
19
82
422
4323
—
—
7
9
434
4391
28
55
390
4278
38
158
316
3639
Erythrocyte [DistWidth] in Red Blood Cells
30385-9 [3002385]
30385-9 [3002385]
1.1e-01
3.6e-01
1.3e+00
2.0e+00
9.0e-01
5.8e-01
1.4e-01
cases:23.36%
controls:21.43%
cases:24.49%
controls:18.43%
cases:14.51%
controls:4.54%
cases:1.81%
controls:0.25%
cases:11.11%
controls:4.84%
cases:29.67%
controls:19.13%
cases:40.40%
controls:37.08%
103
944
338
3461
108
812
333
3593
64
200
377
4205
8
11
433
4394
49
213
392
4187
124
829
294
3504
143
1408
211
2389
Tissue Pathology biopsy report
66121-5 [40768804]
66121-5 [40768804]
4.3e-01
7.6e-01
—
—
1.8e+00
1.2e+00
9.0e-01
cases:11.56%
controls:7.81%
cases:6.80%
controls:3.31%
—
—
—
—
cases:2.27%
controls:0.36%
cases:9.33%
controls:3.07%
cases:21.47%
controls:10.03%
51
344
390
4061
30
146
411
4259
—
—
10
16
431
4384
39
133
379
4200
76
381
278
3416
lansoprazole; oral
A02BC03 [21600098]
A02BC03 [21600098]
1.1e+00
1.2e+00
8.0e-01
—
1.1e+00
1.1e+00
1.1e+00
cases:14.51%
controls:5.22%
cases:7.71%
controls:2.52%
cases:1.36%
controls:0.61%
—
—
cases:1.81%
controls:0.64%
cases:8.85%
controls:3.00%
cases:12.43%
controls:4.32%
64
230
377
4175
34
111
407
4294
6
27
435
4378
—
8
28
433
4372
37
130
381
4203
44
164
310
3633
Diverticular disease of large intestine without perforation or abscess
K57.3 [45567316]
K57.3 [45567316]
5.0e-01
2.0e-01
—
1.0e+50
2.5e+00
1.1e+00
9.5e-01
cases:4.99%
controls:3.09%
cases:1.36%
controls:1.11%
—
—
cases:2.04%
controls:0.00%
cases:1.59%
controls:0.14%
cases:3.35%
controls:1.11%
cases:9.32%
controls:3.82%
22
136
419
4269
6
49
435
4356
—
9
0
432
4405
7
6
434
4394
14
48
404
4285
33
145
321
3652
Plastic And Reconstructive Surgery
24 [38004467]
24 [38004467]
6.9e-01
1.2e+00
2.3e+00
—
1.6e+00
1.1e+00
1.0e+00
cases:5.44%
controls:2.81%
cases:3.17%
controls:1.00%
cases:1.36%
controls:0.14%
—
—
cases:1.13%
controls:0.23%
cases:2.63%
controls:0.90%
cases:8.19%
controls:3.19%
24
124
417
4281
14
44
427
4361
6
6
435
4399
—
5
10
436
4390
11
39
407
4294
29
121
325
3676
Thorax extensive CT-examination
GD1BD [2001303621]
GD1BD [2001303621]
—
—
—
—
—
2.2e+00
2.3e+00
—
—
—
—
—
—
—
—
—
—
cases:1.44%
controls:0.16%
cases:2.54%
controls:0.26%
—
—
—
—
—
6
7
412
4326
9
10
345
3787
Ferritin [Mass/volume] in Serum or Plasma
2276-4 [3001122]
2276-4 [3001122]
5.4e-01
1.1e+00
2.2e+00
—
1.0e+00
7.2e-01
4.9e-01
cases:10.88%
controls:6.63%
cases:11.11%
controls:4.11%
cases:3.40%
controls:0.39%
—
—
cases:1.59%
controls:0.57%
cases:9.57%
controls:4.89%
cases:21.19%
controls:14.20%
48
292
393
4113
49
181
392
4224
15
17
426
4388
—
7
25
434
4375
40
212
378
4121
75
539
279
3258
Calcium.ionized [Moles/volume] in Serum or Plasma
1995-0 [3021347]
1995-0 [3021347]
3.0e-01
5.4e-01
1.5e+00
—
1.6e+00
7.9e-01
5.5e-01
cases:12.24%
controls:9.38%
cases:7.94%
controls:4.77%
cases:3.40%
controls:0.77%
—
—
cases:4.31%
controls:0.93%
cases:10.77%
controls:5.19%
cases:22.88%
controls:14.56%
54
413
387
3992
35
210
406
4195
15
34
426
4371
—
19
41
422
4359
45
225
373
4108
81
553
273
3244
Chloride [Moles/volume] in Serum or Plasma
2075-0 [3014576]
2075-0 [3014576]
6.9e-01
5.8e-01
2.5e+00
—
2.3e+00
1.9e+00
7.1e-01
cases:3.17%
controls:1.61%
cases:1.81%
controls:1.02%
cases:1.59%
controls:0.14%
—
—
cases:1.13%
controls:0.11%
cases:5.74%
controls:0.92%
cases:7.91%
controls:4.06%
14
71
427
4334
8
45
433
4360
7
6
434
4399
—
5
5
436
4395
24
40
394
4293
28
154
326
3643
Pulmonary Disease
29 [38004472]
29 [38004472]
6.7e-01
7.8e-01
1.1e+00
—
1.4e+00
8.7e-01
6.3e-01
cases:17.46%
controls:9.74%
cases:10.88%
controls:5.29%
cases:2.72%
controls:0.95%
—
—
cases:4.31%
controls:1.11%
cases:11.48%
controls:5.15%
cases:18.36%
controls:10.72%
77
429
364
3976
48
233
393
4172
12
42
429
4363
—
19
49
422
4351
48
223
370
4110
65
407
289
3390
Neutrophils/Leukocytes in Blood
26511-6 [3018010]
26511-6 [3018010]
3.5e-01
7.9e-01
1.1e+00
—
1.2e+00
6.5e-01
5.0e-01
cases:12.47%
controls:9.15%
cases:12.47%
controls:6.08%
cases:3.63%
controls:1.20%
—
—
cases:4.08%
controls:1.27%
cases:10.77%
controls:5.91%
cases:23.16%
controls:15.46%
55
403
386
4002
55
268
386
4137
16
53
425
4352
—
18
56
423
4344
45
256
373
4077
82
587
272
3210
darbepoetin alfa; parenteral
B03XA02 [21601134]
B03XA02 [21601134]
—
2.2e+00
—
—
—
2.1e+00
—
—
—
cases:1.36%
controls:0.16%
—
—
—
—
—
—
cases:1.44%
controls:0.18%
—
—
—
6
7
435
4398
—
—
—
6
8
412
4325
—
Inpatient Visit
IP [9201]
IP [9201]
4.8e-01
4.8e-01
1.3e+00
1.0e+50
2.1e+00
1.5e+00
6.1e-01
cases:6.80%
controls:4.34%
cases:3.85%
controls:2.43%
cases:1.36%
controls:0.39%
cases:3.40%
controls:0.00%
cases:3.40%
controls:0.43%
cases:9.81%
controls:2.38%
cases:15.82%
controls:9.27%
30
191
411
4214
17
107
424
4298
6
17
435
4388
15
0
426
4405
15
19
426
4381
41
103
377
4230
56
352
298
3445
Monitoring vital functions without anesthesia
WX000 [2001310756]
WX000 [2001310756]
—
—
—
—
—
2.1e+00
2.1e+00
—
—
—
—
—
—
—
—
—
—
cases:1.44%
controls:0.18%
cases:2.82%
controls:0.34%
—
—
—
—
—
6
8
412
4325
10
13
344
3784
Lymphocytes/Leukocytes in Blood
26478-8 [3002030]
26478-8 [3002030]
3.7e-01
7.5e-01
1.2e+00
—
1.1e+00
6.3e-01
5.0e-01
cases:12.70%
controls:9.15%
cases:12.24%
controls:6.17%
cases:3.63%
controls:1.16%
—
—
cases:4.08%
controls:1.34%
cases:10.77%
controls:6.05%
cases:23.45%
controls:15.62%
56
403
385
4002
54
272
387
4133
16
51
425
4354
—
18
59
423
4341
45
262
373
4071
83
593
271
3204
Neutrophils [#/volume] in Blood by Automated count
751-8 [3013650]
751-8 [3013650]
2.3e-01
7.0e-01
1.1e+00
—
1.1e+00
8.1e-01
4.7e-01
cases:14.51%
controls:11.90%
cases:15.42%
controls:8.29%
cases:4.99%
controls:1.77%
—
—
cases:5.67%
controls:1.93%
cases:16.03%
controls:7.82%
cases:26.84%
controls:18.65%
64
524
377
3881
68
365
373
4040
22
78
419
4327
—
25
85
416
4315
67
339
351
3994
95
708
259
3089
Basophils/Leukocytes in Blood
30180-4 [3022096]
30180-4 [3022096]
2.9e-01
8.0e-01
1.2e+00
—
1.0e+00
6.2e-01
5.5e-01
cases:12.02%
controls:9.31%
cases:12.70%
controls:6.15%
cases:3.63%
controls:1.14%
—
—
cases:3.63%
controls:1.36%
cases:10.53%
controls:5.93%
cases:23.73%
controls:15.28%
53
410
388
3995
56
271
385
4134
16
50
425
4355
—
16
60
425
4340
44
257
374
4076
84
580
270
3217
Monocytes/Leukocytes in Blood
26485-3 [3019069]
26485-3 [3019069]
2.9e-01
7.9e-01
1.2e+00
—
1.0e+00
6.4e-01
5.5e-01
cases:12.02%
controls:9.28%
cases:12.70%
controls:6.17%
cases:3.63%
controls:1.16%
—
—
cases:3.63%
controls:1.36%
cases:10.77%
controls:5.98%
cases:24.01%
controls:15.41%
53
409
388
3996
56
272
385
4133
16
51
425
4354
—
16
60
425
4340
45
259
373
4074
85
585
269
3212
Colonoscopy Study observation
28023-0 [3022145]
28023-0 [3022145]
1.3e+00
1.7e+00
—
1.0e+50
—
1.3e+00
1.2e+00
cases:5.67%
controls:1.68%
cases:3.40%
controls:0.64%
—
—
cases:1.13%
controls:0.00%
—
—
cases:2.39%
controls:0.67%
cases:7.06%
controls:2.26%
25
74
416
4331
15
28
426
4377
—
5
0
436
4405
—
10
29
408
4304
25
86
329
3711
Eosinophils/Leukocytes in Blood
26450-7 [3006504]
26450-7 [3006504]
2.9e-01
8.0e-01
1.2e+00
—
1.0e+00
6.2e-01
5.4e-01
cases:12.02%
controls:9.31%
cases:12.70%
controls:6.15%
cases:3.63%
controls:1.14%
—
—
cases:3.63%
controls:1.36%
cases:10.53%
controls:5.95%
cases:23.73%
controls:15.33%
53
410
388
3995
56
271
385
4134
16
50
425
4355
—
16
60
425
4340
44
258
374
4075
84
582
270
3215
Case Management Agency
251B00000X [38004193]
251B00000X [38004193]
1.5e-01
2.4e-01
5.8e-01
3.0e+00
5.4e-01
1.4e-01
1.6e-01
cases:66.89%
controls:63.43%
cases:61.90%
controls:56.14%
cases:34.47%
controls:22.79%
cases:24.49%
controls:1.61%
cases:34.24%
controls:23.32%
cases:62.92%
controls:59.66%
cases:81.64%
controls:79.12%
295
2794
146
1611
273
2473
168
1932
152
1004
289
3401
108
71
333
4334
151
1026
290
3374
263
2585
155
1748
289
3004
65
793
Infection following a procedure, not elsewhere classified
T81.4 [45575538]
T81.4 [45575538]
7.4e-01
—
—
—
—
2.8e+00
1.2e+00
cases:2.95%
controls:1.43%
—
—
—
—
—
—
—
—
cases:1.91%
controls:0.12%
cases:4.80%
controls:1.45%
13
63
428
4342
—
—
—
—
8
5
410
4328
17
55
337
3742
Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
19072-8 [3016431]
19072-8 [3016431]
3.6e-01
4.9e-01
1.4e+00
—
1.5e+00
7.1e-01
4.7e-01
cases:13.38%
controls:9.76%
cases:8.39%
controls:5.33%
cases:3.40%
controls:0.89%
—
—
cases:3.85%
controls:0.89%
cases:11.72%
controls:6.12%
cases:25.14%
controls:17.30%
59
430
382
3975
37
235
404
4170
15
39
426
4366
—
17
39
424
4361
49
265
369
4068
89
657
265
3140
Physiotherapist
Z3226 [2001311560]
Z3226 [2001311560]
9.4e-01
8.9e-01
—
—
—
1.8e+00
1.3e+00
cases:6.35%
controls:2.59%
cases:1.81%
controls:0.75%
—
—
—
—
—
—
cases:4.31%
controls:0.74%
cases:6.21%
controls:1.74%
28
114
413
4291
8
33
433
4372
—
—
—
18
32
400
4301
22
66
332
3731
Lymphocytes [#/volume] in Blood
26474-7 [3019198]
26474-7 [3019198]
3.4e-01
7.2e-01
1.1e+00
—
1.1e+00
5.8e-01
5.1e-01
cases:13.38%
controls:9.92%
cases:12.93%
controls:6.72%
cases:3.63%
controls:1.20%
—
—
cases:4.08%
controls:1.41%
cases:10.77%
controls:6.32%
cases:24.86%
controls:16.62%
59
437
382
3968
57
296
384
4109
16
53
425
4352
—
18
62
423
4338
45
274
373
4059
88
631
266
3166
Helicobacter pylori Ag [Presence] in Stool
31843-6 [3013139]
31843-6 [3013139]
6.4e-01
1.8e+00
—
—
—
2.1e+00
3.6e-01
cases:2.04%
controls:1.09%
cases:2.27%
controls:0.36%
—
—
—
—
—
—
cases:1.91%
controls:0.23%
cases:1.69%
controls:1.19%
9
48
432
4357
10
16
431
4389
—
—
—
8
10
410
4323
6
45
348
3752
Normoblasts [#/volume] in Blood
715-3 [3021589]
715-3 [3021589]
1.6e-01
6.8e-01
1.1e+00
—
9.8e-01
5.9e-01
5.3e-01
cases:9.30%
controls:8.06%
cases:11.79%
controls:6.36%
cases:4.76%
controls:1.68%
—
—
cases:4.54%
controls:1.75%
cases:11.48%
controls:6.74%
cases:22.88%
controls:14.88%
41
355
400
4050
52
280
389
4125
21
74
420
4331
—
20
77
421
4323
48
292
370
4041
81
565
273
3232
Anesthesiology Critical Care Medicine
OMOP4821991 [45756751]
OMOP4821991 [45756751]
6.8e-01
1.3e+00
—
—
—
2.2e+00
1.6e+00
cases:2.04%
controls:1.04%
cases:1.59%
controls:0.45%
—
—
—
—
—
—
cases:2.63%
controls:0.30%
cases:5.08%
controls:1.08%
9
46
432
4359
7
20
434
4385
—
—
—
11
13
407
4320
18
41
336
3756
Chronic kidney disease, unspecified
N18.9 [45553438]
N18.9 [45553438]
1.4e+00
1.3e+00
—
—
2.3e+00
1.1e+00
2.6e-01
cases:2.72%
controls:0.66%
cases:1.81%
controls:0.52%
—
—
—
—
cases:1.36%
controls:0.14%
cases:1.67%
controls:0.58%
cases:1.69%
controls:1.32%
12
29
429
4376
8
23
433
4382
—
—
6
6
435
4394
7
25
411
4308
6
50
348
3747
Infectious Disease
44 [38004484]
44 [38004484]
6.9e-01
1.4e+00
—
—
—
1.3e+00
1.0e+00
cases:3.85%
controls:1.98%
cases:3.17%
controls:0.84%
—
—
—
—
—
—
cases:3.11%
controls:0.83%
cases:4.80%
controls:1.82%
17
87
424
4318
14
37
427
4368
—
—
—
13
36
405
4297
17
69
337
3728
Monocytes [#/volume] in Blood
26484-6 [3001604]
26484-6 [3001604]
3.0e-01
7.5e-01
1.1e+00
—
1.1e+00
5.7e-01
5.4e-01
cases:12.47%
controls:9.56%
cases:12.93%
controls:6.54%
cases:3.40%
controls:1.14%
—
—
cases:3.85%
controls:1.34%
cases:10.53%
controls:6.25%
cases:24.86%
controls:16.12%
55
421
386
3984
57
288
384
4117
15
50
426
4355
—
17
59
424
4341
44
271
374
4062
88
612
266
3185
Eosinophils [#/volume] in Blood
26449-9 [3013115]
26449-9 [3013115]
2.4e-01
7.7e-01
1.1e+00
—
1.1e+00
5.5e-01
5.3e-01
cases:12.70%
controls:10.31%
cases:13.61%
controls:6.77%
cases:3.63%
controls:1.20%
—
—
cases:4.08%
controls:1.45%
cases:10.77%
controls:6.53%
cases:25.71%
controls:16.96%
56
454
385
3951
60
298
381
4107
16
53
425
4352
—
18
64
423
4336
45
283
373
4050
91
644
263
3153
Pathology report gross observation
24419-4 [3002256]
24419-4 [3002256]
2.9e-01
—
—
—
1.6e+00
2.6e+00
9.1e-01
cases:3.40%
controls:2.57%
—
—
—
—
—
—
cases:1.13%
controls:0.23%
cases:6.22%
controls:0.51%
cases:6.78%
controls:2.84%
15
113
426
4292
—
—
—
5
10
436
4390
26
22
392
4311
24
108
330
3689
Basophils [#/volume] in Blood
26444-0 [3006315]
26444-0 [3006315]
3.0e-01
7.5e-01
1.1e+00
—
1.1e+00
5.7e-01
5.3e-01
cases:12.47%
controls:9.56%
cases:12.93%
controls:6.56%
cases:3.40%
controls:1.14%
—
—
cases:3.85%
controls:1.36%
cases:10.53%
controls:6.25%
cases:24.58%
controls:16.14%
55
421
386
3984
57
289
384
4116
15
50
426
4355
—
17
60
424
4340
44
271
374
4062
87
613
267
3184
pH of Serum or Plasma
2753-2 [3018418]
2753-2 [3018418]
2.7e-01
5.2e-01
1.6e+00
—
1.8e+00
5.7e-01
5.2e-01
cases:7.26%
controls:5.65%
cases:5.22%
controls:3.16%
cases:2.49%
controls:0.50%
—
—
cases:2.49%
controls:0.43%
cases:5.74%
controls:3.32%
cases:15.25%
controls:9.64%
32
249
409
4156
23
139
418
4266
11
22
430
4383
—
11
19
430
4381
24
144
394
4189
54
366
300
3431
Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
54067-4 [3051552]
54067-4 [3051552]
1.3e+00
—
—
—
—
2.1e+00
7.9e-01
cases:3.40%
controls:0.95%
—
—
—
—
—
—
—
—
cases:2.15%
controls:0.28%
cases:4.52%
controls:2.11%
15
42
426
4363
—
—
—
—
9
12
409
4321
16
80
338
3717
Other transluminal endoscopic operation on stomach or duodenum
JDW98 [2001304774]
JDW98 [2001304774]
—
—
—
—
1.0e+50
—
3.3e+00
—
—
—
—
—
—
—
—
cases:1.36%
controls:0.00%
—
—
cases:4.24%
controls:0.16%
—
—
—
—
6
0
435
4400
—
15
6
339
3791
Intravenous general anesthesia
WX404 [2001310807]
WX404 [2001310807]
3.7e-01
1.2e+00
—
—
—
1.9e+00
1.5e+00
cases:5.44%
controls:3.81%
cases:2.72%
controls:0.84%
—
—
—
—
—
—
cases:3.59%
controls:0.58%
cases:6.21%
controls:1.50%
24
168
417
4237
12
37
429
4368
—
—
—
15
25
403
4308
22
57
332
3740
X-ray examination of the lungs in one projection
GD1PA [2001303645]
GD1PA [2001303645]
3.6e-01
1.7e+00
—
—
—
1.6e+00
2.1e-01
cases:1.59%
controls:1.11%
cases:2.27%
controls:0.41%
—
—
—
—
—
—
cases:2.63%
controls:0.55%
cases:1.98%
controls:1.61%
7
49
434
4356
10
18
431
4387
—
—
—
11
24
407
4309
7
61
347
3736
Immunohistochemistry procedure
117617002 [4035726]
117617002 [4035726]
3.9e-01
9.2e-01
—
—
1.0e+50
2.0e+00
1.3e+00
cases:2.49%
controls:1.70%
cases:1.59%
controls:0.64%
—
—
—
—
cases:1.13%
controls:0.00%
cases:2.87%
controls:0.39%
cases:5.08%
controls:1.47%
11
75
430
4330
7
28
434
4377
—
—
5
0
436
4400
12
17
406
4316
18
56
336
3741
ABO and Rh group [Type] in Blood
882-1 [3003694]
882-1 [3003694]
4.0e-01
4.9e-01
2.0e+00
—
—
1.3e+00
3.9e-01
cases:5.90%
controls:4.04%
cases:2.27%
controls:1.41%
cases:1.81%
controls:0.25%
—
—
—
—
cases:2.87%
controls:0.81%
cases:7.34%
controls:5.11%
26
178
415
4227
10
62
431
4343
8
11
433
4394
—
—
12
35
406
4298
26
194
328
3603
salmeterol and fluticasone
R03AK06 [21603280]
R03AK06 [21603280]
9.1e-01
1.2e+00
1.3e+00
—
8.9e-01
1.1e+00
6.3e-01
cases:7.71%
controls:3.25%
cases:6.80%
controls:2.20%
cases:2.04%
controls:0.57%
—
—
cases:1.59%
controls:0.66%
cases:5.98%
controls:2.03%
cases:6.21%
controls:3.40%
34
143
407
4262
30
97
411
4308
9
25
432
4380
—
7
29
434
4371
25
88
393
4245
22
129
332
3668
Multidisciplinary treatment meeting
WZC20 [2001310890]
WZC20 [2001310890]
-1.0e+50
—
—
—
—
3.2e+00
—
cases:0.00%
controls:0.39%
—
—
—
—
—
—
—
—
cases:2.63%
controls:0.12%
—
—
0
17
441
4388
—
—
—
—
11
5
407
4328
—
Iron/Transferrin [Ratio] in Serum or Plasma
60517-0 [40763571]
60517-0 [40763571]
9.2e-01
1.3e+00
—
—
-1.0e+50
6.3e-01
8.3e-01
cases:4.76%
controls:1.95%
cases:3.85%
controls:1.04%
—
—
—
—
cases:0.00%
controls:0.30%
cases:2.39%
controls:1.29%
cases:8.76%
controls:4.00%
21
86
420
4319
17
46
424
4359
—
—
0
13
441
4387
10
56
408
4277
31
152
323
3645
Cathetrisation of vein
TPH04 [2001309597]
TPH04 [2001309597]
8.0e-01
6.4e-01
—
1.0e+50
1.8e+00
1.6e+00
7.1e-01
cases:6.35%
controls:2.95%
cases:2.27%
controls:1.20%
—
—
cases:1.81%
controls:0.00%
cases:1.13%
controls:0.18%
cases:5.02%
controls:1.08%
cases:8.19%
controls:4.19%
28
130
413
4275
10
53
431
4352
—
8
0
433
4405
5
8
436
4392
21
47
397
4286
29
159
325
3638
General anesthesia, balanced
WX408 [2001310808]
WX408 [2001310808]
2.0e-01
-4.1e-02
—
1.0e+50
2.1e+00
1.6e+00
1.5e+00
cases:5.44%
controls:4.49%
cases:1.13%
controls:1.18%
—
—
cases:1.36%
controls:0.00%
cases:1.13%
controls:0.14%
cases:3.11%
controls:0.65%
cases:9.04%
controls:2.19%
24
198
417
4207
5
52
436
4353
—
6
0
435
4405
5
6
436
4394
13
28
405
4305
32
83
322
3714
Iron [Moles/volume] in Serum or Plasma
14798-3 [3022948]
14798-3 [3022948]
9.2e-01
1.3e+00
—
—
—
7.9e-01
7.8e-01
cases:5.67%
controls:2.34%
cases:4.54%
controls:1.29%
—
—
—
—
—
—
cases:3.11%
controls:1.43%
cases:10.17%
controls:4.92%
25
103
416
4302
20
57
421
4348
—
—
—
13
62
405
4271
36
187
318
3610
Emergency Room and Inpatient Visit
ERIP [262]
ERIP [262]
3.8e-01
6.8e-01
1.4e+00
—
2.1e+00
8.7e-01
1.9e-01
cases:4.76%
controls:3.29%
cases:4.08%
controls:2.11%
cases:1.13%
controls:0.27%
—
—
cases:2.04%
controls:0.25%
cases:6.22%
controls:2.70%
cases:12.71%
controls:10.77%
21
145
420
4260
18
93
423
4312
5
12
436
4393
—
9
11
432
4389
26
117
392
4216
45
409
309
3388
Ileoscopy through colon
UJF30 [2001305028]
UJF30 [2001305028]
9.0e-01
1.9e+00
—
—
—
—
1.1e+00
cases:3.17%
controls:1.32%
cases:2.49%
controls:0.39%
—
—
—
—
—
—
—
—
cases:3.67%
controls:1.29%
14
58
427
4347
11
17
430
4388
—
—
—
—
13
49
341
3748
Radical radiotherapy
WF002 [2001310701]
WF002 [2001310701]
—
-1.0e+50
—
—
—
2.9e+00
—
—
—
cases:0.00%
controls:0.18%
—
—
—
—
—
—
cases:2.15%
controls:0.12%
—
—
—
0
8
441
4397
—
—
—
9
5
409
4328
—
Examination and observation for other specified reasons
Z04.8 [45552063]
Z04.8 [45552063]
4.9e-01
1.5e+00
—
—
—
1.4e+00
5.5e-01
cases:2.27%
controls:1.41%
cases:2.04%
controls:0.45%
—
—
—
—
—
—
cases:2.39%
controls:0.60%
cases:3.67%
controls:2.16%
10
62
431
4343
9
20
432
4385
—
—
—
10
26
408
4307
13
82
341
3715
Ultrasound examination of upper part of abdomen
JN1AE [2001305517]
JN1AE [2001305517]
1.3e+00
1.7e+00
—
—
—
—
1.5e+00
cases:2.95%
controls:0.79%
cases:1.13%
controls:0.20%
—
—
—
—
—
—
—
—
cases:3.95%
controls:0.87%
13
35
428
4370
5
9
436
4396
—
—
—
—
14
33
340
3764
Essential (primary) hypertension
I10 [45591453]
I10 [45591453]
3.6e-01
2.2e-01
1.1e+00
—
1.3e+00
5.2e-01
8.9e-02
cases:25.17%
controls:19.00%
cases:12.02%
controls:9.90%
cases:3.85%
controls:1.36%
—
—
cases:4.54%
controls:1.30%
cases:15.55%
controls:9.83%
cases:29.38%
controls:27.57%
111
837
330
3568
53
436
388
3969
17
60
424
4345
—
20
57
421
4343
65
426
353
3907
104
1047
250
2750
Functional dyspepsia
K30 [45591584]
K30 [45591584]
1.0e+00
1.9e+00
—
—
—
1.5e+00
5.0e-01
cases:3.40%
controls:1.27%
cases:2.72%
controls:0.43%
—
—
—
—
—
—
cases:1.91%
controls:0.42%
cases:2.82%
controls:1.74%
15
56
426
4349
12
19
429
4386
—
—
—
8
18
410
4315
10
66
344
3731
12 lead EKG panel
34534-8 [3044889]
34534-8 [3044889]
-2.9e-03
4.3e-01
1.1e+00
—
1.0e+00
7.4e-01
2.6e-01
cases:17.69%
controls:17.73%
cases:14.29%
controls:9.81%
cases:3.40%
controls:1.14%
—
—
cases:3.40%
controls:1.27%
cases:17.46%
controls:9.16%
cases:32.49%
controls:27.10%
78
781
363
3624
63
432
378
3973
15
50
426
4355
—
15
56
426
4344
73
397
345
3936
115
1029
239
2768
Pain localized to upper abdomen
R10.1 [45568111]
R10.1 [45568111]
4.3e-01
1.9e+00
—
—
—
1.3e+00
9.6e-01
cases:3.40%
controls:2.25%
cases:3.40%
controls:0.52%
—
—
—
—
—
—
cases:2.15%
controls:0.60%
cases:6.78%
controls:2.71%
15
99
426
4306
15
23
426
4382
—
—
—
9
26
409
4307
24
103
330
3694
Transferrin [Mass/volume] in Serum or Plasma
3034-6 [3004789]
3034-6 [3004789]
8.4e-01
1.2e+00
—
—
-1.0e+50
7.4e-01
8.0e-01
cases:4.76%
controls:2.11%
cases:3.63%
controls:1.14%
—
—
—
—
cases:0.00%
controls:0.30%
cases:2.87%
controls:1.38%
cases:9.04%
controls:4.29%
21
93
420
4312
16
50
425
4355
—
—
0
13
441
4387
12
60
406
4273
32
163
322
3634
oxycodone; oral, parenteral
N02AA05 [21604260]
N02AA05 [21604260]
6.9e-01
4.2e-01
—
—
1.5e+00
1.3e+00
5.8e-01
cases:2.95%
controls:1.50%
cases:1.59%
controls:1.04%
—
—
—
—
cases:2.04%
controls:0.45%
cases:4.55%
controls:1.29%
cases:6.78%
controls:3.92%
13
66
428
4339
7
46
434
4359
—
—
9
20
432
4380
19
56
399
4277
24
149
330
3648
Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M
77147-7 [46236952]
77147-7 [46236952]
6.1e-01
1.4e+00
—
—
—
1.4e+00
3.6e-01
cases:2.27%
controls:1.25%
cases:2.49%
controls:0.61%
—
—
—
—
—
—
cases:2.39%
controls:0.62%
cases:2.54%
controls:1.79%
10
55
431
4350
11
27
430
4378
—
—
—
10
27
408
4306
9
68
345
3729
Malignant tumour
130 [2001600128]
130 [2001600128]
—
—
—
—
—
2.8e+00
7.8e-01
—
—
—
—
—
—
—
—
—
—
cases:4.31%
controls:0.28%
cases:2.26%
controls:1.05%
—
—
—
—
—
18
12
400
4321
8
40
346
3757
Cervical spine X-ray examination without contrast
NA1AA [2001306981]
NA1AA [2001306981]
1.6e+00
—
—
—
—
—
2.7e+00
cases:1.36%
controls:0.27%
—
—
—
—
—
—
—
—
—
—
cases:1.98%
controls:0.13%
6
12
435
4393
—
—
—
—
—
7
5
347
3792
Dietary counselling and surveillance
Z71.3 [45552101]
Z71.3 [45552101]
—
—
—
—
—
2.7e+00
—
—
—
—
—
—
—
—
—
—
—
cases:1.67%
controls:0.12%
—
—
—
—
—
—
—
7
5
411
4328
—
Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
30248-9 [3015399]
30248-9 [3015399]
7.0e-01
1.3e+00
—
—
1.7e+00
7.0e-01
6.0e-01
cases:8.16%
controls:4.22%
cases:8.16%
controls:2.27%
—
—
—
—
cases:1.59%
controls:0.30%
cases:4.78%
controls:2.45%
cases:14.12%
controls:8.27%
36
186
405
4219
36
100
405
4305
—
—
7
13
434
4387
20
106
398
4227
50
314
304
3483
Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1920-8 [3013721]
1920-8 [3013721]
3.1e-01
8.1e-01
1.6e+00
—
1.3e+00
1.1e+00
7.4e-01
cases:7.94%
controls:5.97%
cases:5.90%
controls:2.70%
cases:1.59%
controls:0.32%
—
—
cases:2.04%
controls:0.59%
cases:8.13%
controls:2.88%
cases:17.80%
controls:9.38%
35
263
406
4142
26
119
415
4286
7
14
434
4391
—
9
26
432
4374
34
125
384
4208
63
356
291
3441
Differential panel, method unspecified - Blood
69738-3 [42870588]
69738-3 [42870588]
3.7e-01
6.7e-01
1.3e+00
—
8.0e-01
6.3e-01
6.5e-01
cases:9.07%
controls:6.45%
cases:8.39%
controls:4.47%
cases:2.72%
controls:0.75%
—
—
cases:2.49%
controls:1.14%
cases:7.42%
controls:4.11%
cases:18.36%
controls:10.48%
40
284
401
4121
37
197
404
4208
12
33
429
4372
—
11
50
430
4350
31
178
387
4155
65
398
289
3399
Medical Oncology
90 [38004507]
90 [38004507]
1.1e-01
4.0e-01
4.0e-01
—
1.4e+00
1.2e+00
5.5e-01
cases:4.76%
controls:4.27%
cases:4.76%
controls:3.25%
cases:1.81%
controls:1.23%
—
—
cases:4.08%
controls:1.07%
cases:10.77%
controls:3.53%
cases:9.04%
controls:5.40%
21
188
420
4217
21
143
420
4262
8
54
433
4351
—
18
47
423
4353
45
153
373
4180
32
205
322
3592
General Practice
1 [38004446]
1 [38004446]
3.3e-01
7.6e-01
8.4e-01
—
1.1e+00
6.8e-01
3.9e-01
cases:17.23%
controls:13.08%
cases:11.11%
controls:5.54%
cases:1.81%
controls:0.79%
—
—
cases:2.95%
controls:0.98%
cases:10.77%
controls:5.77%
cases:22.88%
controls:16.75%
76
576
365
3829
49
244
392
4161
8
35
433
4370
—
13
43
428
4357
45
250
373
4083
81
636
273
3161
Magnesium [Moles/volume] in Serum or Plasma
2601-3 [3012095]
2601-3 [3012095]
5.6e-01
9.5e-01
1.9e+00
—
1.7e+00
1.5e+00
1.0e+00
cases:4.54%
controls:2.63%
cases:3.63%
controls:1.43%
cases:1.36%
controls:0.20%
—
—
cases:1.59%
controls:0.30%
cases:6.70%
controls:1.57%
cases:11.30%
controls:4.29%
20
116
421
4289
16
63
425
4342
6
9
435
4396
—
7
13
434
4387
28
68
390
4265
40
163
314
3634
Abdominal X-ray examination without contrast
JN3AA [2001305553]
JN3AA [2001305553]
-1.0e+50
2.1e+00
—
—
—
—
2.5e+00
cases:0.00%
controls:0.45%
cases:1.13%
controls:0.14%
—
—
—
—
—
—
—
—
cases:2.26%
controls:0.18%
0
20
441
4385
5
6
436
4399
—
—
—
—
8
7
346
3790
Gastro-oesophageal reflux disease
K21 [45586708]
K21 [45586708]
—
2.5e+00
—
—
—
2.0e+00
8.4e-01
—
—
cases:2.49%
controls:0.20%
—
—
—
—
—
—
cases:1.20%
controls:0.16%
cases:1.69%
controls:0.74%
—
11
9
430
4396
—
—
—
5
7
413
4326
6
28
348
3769
Sedation and analgesia
WX002 [2001310758]
WX002 [2001310758]
4.9e-01
5.8e-01
-1.0e+50
1.0e+50
—
1.4e+00
1.1e+00
cases:5.22%
controls:3.27%
cases:1.13%
controls:0.64%
cases:0.00%
controls:0.11%
cases:4.08%
controls:0.00%
—
—
cases:3.59%
controls:0.88%
cases:7.34%
controls:2.63%
23
144
418
4261
5
28
436
4377
0
5
441
4400
18
0
423
4405
—
15
38
403
4295
26
100
328
3697
fluconazole; oral, parenteral
J02AC01 [21603080]
J02AC01 [21603080]
6.1e-01
1.0e+00
—
—
—
7.5e-01
8.6e-01
cases:10.66%
controls:6.06%
cases:5.44%
controls:2.02%
—
—
—
—
—
—
cases:3.83%
controls:1.85%
cases:10.73%
controls:4.85%
47
267
394
4138
24
89
417
4316
—
—
—
16
80
402
4253
38
184
316
3613
cyanocobalamin, combinations
B03BA51 [21601126]
B03BA51 [21601126]
2.5e+00
—
—
—
—
—
—
cases:1.36%
controls:0.11%
—
—
—
—
—
—
—
—
—
—
—
—
6
5
435
4400
—
—
—
—
—
—
dalteparin; parenteral
B01AB04 [21600975]
B01AB04 [21600975]
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
cases:2.15%
controls:0.18%
—
—
—
—
—
—
—
9
8
409
4325
—
ispaghula (psylla seeds); oral
A06AC01 [21600555]
A06AC01 [21600555]
7.3e-01
9.4e-01
—
—
8.8e-01
4.3e-01
8.0e-01
cases:7.94%
controls:3.97%
cases:5.67%
controls:2.29%
—
—
—
—
cases:1.36%
controls:0.57%
cases:3.59%
controls:2.35%
cases:11.30%
controls:5.43%
35
175
406
4230
25
101
416
4304
—
—
6
25
435
4375
15
102
403
4231
40
206
314
3591
Repeated or continuing anesthesia shots throug a catheter
WX602 [2001310813]
WX602 [2001310813]
—
-1.0e+50
—
—
—
2.5e+00
9.0e-01
—
—
cases:0.00%
controls:0.36%
—
—
—
—
—
—
cases:2.39%
controls:0.21%
cases:1.98%
controls:0.82%
—
0
16
441
4389
—
—
—
10
9
408
4324
7
31
347
3766
granisetron; oral, parenteral, transdermal
A04AA02 [21600494]
A04AA02 [21600494]
—
—
—
—
—
2.5e+00
—
—
—
—
—
—
—
—
—
—
—
cases:2.63%
controls:0.23%
—
—
—
—
—
—
—
11
10
407
4323
—
Hemoglobin.gastrointestinal [Presence] in Stool
2335-8 [3016251]
2335-8 [3016251]
6.2e-01
2.4e+00
—
—
—
—
1.8e-01
cases:1.59%
controls:0.86%
cases:2.27%
controls:0.20%
—
—
—
—
—
—
—
—
cases:1.41%
controls:1.19%
7
38
434
4367
10
9
431
4396
—
—
—
—
5
45
349
3752
orphenadrine, combinations
M03BC51 [21604113]
M03BC51 [21604113]
7.6e-01
7.2e-01
—
—
—
1.6e+00
6.8e-01
cases:7.03%
controls:3.43%
cases:2.72%
controls:1.34%
—
—
—
—
—
—
cases:3.11%
controls:0.62%
cases:5.08%
controls:2.63%
31
151
410
4254
12
59
429
4346
—
—
—
13
27
405
4306
18
100
336
3697
acetylcysteine; inhalant, oral
R05CB01 [21603380]
R05CB01 [21603380]
-1.0e+50
—
—
—
—
2.3e+00
—
cases:0.00%
controls:0.16%
—
—
—
—
—
—
—
—
cases:1.20%
controls:0.12%
—
—
0
7
441
4398
—
—
—
—
5
5
413
4328
—
Hemodialysis
TK800 [2001305768]
TK800 [2001305768]
—
—
—
—
—
2.3e+00
—
—
—
—
—
—
—
—
—
—
—
cases:1.20%
controls:0.12%
—
—
—
—
—
—
—
5
5
413
4328
—
acetylcysteine
V03AB23 [21605248]
V03AB23 [21605248]
-1.0e+50
—
—
—
—
2.3e+00
—
cases:0.00%
controls:0.16%
—
—
—
—
—
—
—
—
cases:1.20%
controls:0.12%
—
—
0
7
441
4398
—
—
—
—
5
5
413
4328
—
paracetamol, combinations excl. psycholeptics
N02BE51 [21604348]
N02BE51 [21604348]
7.8e-01
6.7e-01
—
—
—
1.6e+00
6.5e-01
cases:7.48%
controls:3.59%
cases:2.72%
controls:1.41%
—
—
—
—
—
—
cases:3.11%
controls:0.67%
cases:5.08%
controls:2.71%
33
158
408
4247
12
62
429
4343
—
—
—
13
29
405
4304
18
103
336
3694
Family history of malignant neoplasm of breast
Z80.3 [45556856]
Z80.3 [45556856]
2.3e+00
—
—
—
—
—
—
cases:1.59%
controls:0.16%
—
—
—
—
—
—
—
—
—
—
—
—
7
7
434
4398
—
—
—
—
—
—
Respiratory and circulatory monitoring
WX700 [2001310817]
WX700 [2001310817]
5.2e-01
1.0e+00
—
—
—
1.4e+00
9.5e-01
cases:3.85%
controls:2.34%
cases:1.81%
controls:0.66%
—
—
—
—
—
—
cases:2.63%
controls:0.69%
cases:6.21%
controls:2.50%
17
103
424
4302
8
29
433
4376
—
—
—
11
30
407
4303
22
95
332
3702
Bicarbonate [Moles/volume] standard in Arterial blood
19230-2 [3014218]
19230-2 [3014218]
5.8e-01
-1.0e+50
—
—
—
2.3e+00
1.1e+00
cases:1.13%
controls:0.64%
cases:0.00%
controls:0.30%
—
—
—
—
—
—
cases:2.15%
controls:0.23%
cases:3.39%
controls:1.21%
5
28
436
4377
0
13
441
4392
—
—
—
9
10
409
4323
12
46
342
3751
Diarrhoea
D11 [2002000310]
D11 [2002000310]
1.2e+00
—
—
—
—
—
1.1e+00
cases:3.63%
controls:1.16%
—
—
—
—
—
—
—
—
—
—
cases:4.52%
controls:1.61%
16
51
425
4354
—
—
—
—
—
16
61
338
3736
Thorax X-ray examination outside radiological department
GD1UA [2001303652]
GD1UA [2001303652]
5.0e-01
3.8e-01
—
—
—
2.2e+00
3.8e-01
cases:3.85%
controls:2.38%
cases:1.36%
controls:0.93%
—
—
—
—
—
—
cases:4.78%
controls:0.55%
cases:4.24%
controls:2.95%
17
105
424
4300
6
41
435
4364
—
—
—
20
24
398
4309
15
112
339
3685
More than one and less than three hours
ZXE10 [2001311401]
ZXE10 [2001311401]
3.5e-01
4.5e-01
—
—
2.1e+00
1.1e+00
1.1e+00
cases:9.52%
controls:6.92%
cases:2.72%
controls:1.75%
—
—
—
—
cases:1.13%
controls:0.14%
cases:4.31%
controls:1.43%
cases:10.45%
controls:3.90%
42
305
399
4100
12
77
429
4328
—
—
5
6
436
4394
18
62
400
4271
37
148
317
3649
enoxaparin; parenteral
B01AB05 [21600976]
B01AB05 [21600976]
4.5e-02
5.7e-01
1.8e+00
—
1.6e+00
1.3e+00
8.8e-01
cases:5.90%
controls:5.65%
cases:3.17%
controls:1.82%
cases:1.36%
controls:0.23%
—
—
cases:1.59%
controls:0.34%
cases:6.22%
controls:1.78%
cases:11.30%
controls:5.00%
26
249
415
4156
14
80
427
4325
6
10
435
4395
—
7
15
434
4385
26
77
392
4256
40
190
314
3607
potassium chloride; oral
A12BA01 [21600877]
A12BA01 [21600877]
2.0e-01
1.0e+00
—
—
—
1.1e+00
3.2e-01
cases:2.49%
controls:2.04%
cases:3.40%
controls:1.23%
—
—
—
—
—
—
cases:4.31%
controls:1.45%
cases:4.24%
controls:3.11%
11
90
430
4315
15
54
426
4351
—
—
—
18
63
400
4270
15
118
339
3679
Abnormal findings on diagnostic imaging of lung
R91 [45548995]
R91 [45548995]
7.6e-01
1.4e+00
—
—
—
2.2e+00
1.6e-01
cases:2.72%
controls:1.29%
cases:2.04%
controls:0.50%
—
—
—
—
—
—
cases:2.15%
controls:0.25%
cases:1.41%
controls:1.21%
12
57
429
4348
9
22
432
4383
—
—
—
9
11
409
4322
5
46
349
3751
Body CT examination
JN4AD [2001310897]
JN4AD [2001310897]
8.9e-01
1.4e+00
—
1.0e+50
—
2.1e+00
6.7e-01
cases:1.81%
controls:0.75%
cases:1.81%
controls:0.45%
—
—
cases:1.36%
controls:0.00%
—
—
cases:3.83%
controls:0.46%
cases:3.95%
controls:2.05%
8
33
433
4372
8
20
433
4385
—
6
0
435
4405
—
16
20
402
4313
14
78
340
3719
moxifloxacin; oral, parenteral
J01MA14 [21603021]
J01MA14 [21603021]
6.6e-01
—
—
—
—
2.1e+00
8.0e-01
cases:2.04%
controls:1.07%
—
—
—
—
—
—
—
—
cases:1.91%
controls:0.23%
cases:2.26%
controls:1.03%
9
47
432
4358
—
—
—
—
8
10
410
4323
8
39
346
3758
Cardiac arrhythmia NOS
K80 [2002000607]
K80 [2002000607]
4.9e-01
—
—
—
—
2.1e+00
5.7e-01
cases:1.59%
controls:0.98%
—
—
—
—
—
—
—
—
cases:1.67%
controls:0.21%
cases:1.98%
controls:1.13%
7
43
434
4362
—
—
—
—
7
9
411
4324
7
43
347
3754
Rubber band ligature of haemorrhoids or prolapse of mucosa
JHB30 [2001305142]
JHB30 [2001305142]
9.7e-01
—
—
—
—
-1.0e+50
2.1e+00
cases:1.36%
controls:0.52%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.16%
cases:1.69%
controls:0.21%
6
23
435
4382
—
—
—
—
0
7
418
4326
6
8
348
3789
Demanding cystostatic therapy of methastized malignancy
WD125 [2001310680]
WD125 [2001310680]
—
—
—
—
—
2.1e+00
8.1e-01
—
—
—
—
—
—
—
—
—
—
cases:2.15%
controls:0.28%
cases:1.41%
controls:0.63%
—
—
—
—
—
9
12
409
4321
5
24
349
3773
Troponin I.cardiac [Mass/volume] in Serum or Plasma
10839-9 [3021337]
10839-9 [3021337]
2.6e-01
5.2e-01
2.1e+00
—
—
5.3e-01
4.7e-01
cases:4.08%
controls:3.18%
cases:2.95%
controls:1.77%
cases:1.59%
controls:0.20%
—
—
—
—
cases:2.87%
controls:1.71%
cases:9.60%
controls:6.22%
18
140
423
4265
13
78
428
4327
7
9
434
4396
—
—
12
74
406
4259
34
236
320
3561
Ulcerative colitis and Crohn's disease
208 [2001600206]
208 [2001600206]
2.1e+00
—
—
—
—
—
-1.0e+50
cases:1.59%
controls:0.20%
—
—
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.13%
7
9
434
4396
—
—
—
—
—
0
5
354
3792
Bicarbonate [Moles/volume] in Serum or Plasma
1963-8 [3016293]
1963-8 [3016293]
8.0e-01
—
—
—
—
2.0e+00
1.0e+00
cases:1.36%
controls:0.61%
—
—
—
—
—
—
—
—
cases:3.11%
controls:0.42%
cases:3.95%
controls:1.47%
6
27
435
4378
—
—
—
—
13
18
405
4315
14
56
340
3741
Arthropathic psoriasis
L40.5 [45557703]
L40.5 [45557703]
1.6e+00
—
—
—
—
—
2.0e+00
cases:1.36%
controls:0.27%
—
—
—
—
—
—
—
—
—
—
cases:1.98%
controls:0.26%
6
12
435
4393
—
—
—
—
—
7
10
347
3787
Influenza virus A+B Ag [Presence] in Specimen
24015-0 [3024891]
24015-0 [3024891]
—
—
—
—
—
—
2.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.54%
controls:0.34%
—
—
—
—
—
—
9
13
345
3784
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
Y83.9 [45547252]
Y83.9 [45547252]
2.0e+00
—
—
—
—
—
—
cases:1.36%
controls:0.18%
—
—
—
—
—
—
—
—
—
—
—
—
6
8
435
4397
—
—
—
—
—
—
Sodium and Potassium panel [Moles/volume] - Serum or Plasma
34548-8 [3045783]
34548-8 [3045783]
5.4e-01
5.4e-01
—
—
2.0e+00
2.2e-01
-2.3e-01
cases:6.12%
controls:3.65%
cases:2.72%
controls:1.61%
—
—
—
—
cases:1.36%
controls:0.18%
cases:2.15%
controls:1.73%
cases:3.11%
controls:3.90%
27
161
414
4244
12
71
429
4334
—
—
6
8
435
4392
9
75
409
4258
11
148
343
3649
Other psoriatic arthropathies
M07.3*L40.5 [2000503010]
M07.3*L40.5 [2000503010]
2.0e+00
2.0e+00
—
—
—
1.6e+00
1.7e+00
cases:1.81%
controls:0.25%
cases:1.13%
controls:0.16%
—
—
—
—
—
—
cases:1.20%
controls:0.25%
cases:1.69%
controls:0.32%
8
11
433
4394
5
7
436
4398
—
—
—
5
11
413
4322
6
12
348
3785
Gas panel - Venous blood
24339-4 [3000991]
24339-4 [3000991]
6.4e-01
—
—
—
—
2.0e+00
6.8e-01
cases:1.59%
controls:0.84%
—
—
—
—
—
—
—
—
cases:4.07%
controls:0.58%
cases:5.08%
controls:2.63%
7
37
434
4368
—
—
—
—
17
25
401
4308
18
100
336
3697
Carboxyhemoglobin/Hemoglobin.total in Arterial blood
2030-5 [3028653]
2030-5 [3028653]
8.1e-01
—
—
—
—
2.0e+00
6.9e-01
cases:1.81%
controls:0.82%
—
—
—
—
—
—
—
—
cases:2.39%
controls:0.35%
cases:3.67%
controls:1.87%
8
36
433
4369
—
—
—
—
10
15
408
4318
13
71
341
3726
Methemoglobin/Hemoglobin.total in Arterial blood
2615-3 [3006217]
2615-3 [3006217]
8.4e-01
—
—
—
—
2.0e+00
8.0e-01
cases:1.81%
controls:0.79%
—
—
—
—
—
—
—
—
cases:2.39%
controls:0.35%
cases:3.95%
controls:1.82%
8
35
433
4370
—
—
—
—
10
15
408
4318
14
69
340
3728
Bicarbonate [Moles/volume] standard in Venous blood
19232-8 [3007628]
19232-8 [3007628]
1.2e+00
—
—
—
—
2.0e+00
8.2e-01
cases:1.13%
controls:0.34%
—
—
—
—
—
—
—
—
cases:2.39%
controls:0.35%
cases:3.67%
controls:1.66%
5
15
436
4390
—
—
—
—
10
15
408
4318
13
63
341
3734
Oxygen capacity [Volume Fraction] in Arterial blood
59275-8 [40762366]
59275-8 [40762366]
—
-1.0e+50
—
—
—
2.0e+00
9.6e-01
—
—
cases:0.00%
controls:0.25%
—
—
—
—
—
—
cases:2.39%
controls:0.35%
cases:3.95%
controls:1.55%
—
0
11
441
4394
—
—
—
10
15
408
4318
14
59
340
3738
IgA [Mass/volume] in Serum or Plasma
2458-8 [3007164]
2458-8 [3007164]
8.6e-01
1.1e+00
1.0e+50
—
—
—
2.1e-01
cases:6.35%
controls:2.79%
cases:3.63%
controls:1.25%
cases:1.59%
controls:0.00%
—
—
—
—
—
—
cases:5.08%
controls:4.16%
28
123
413
4282
16
55
425
4350
7
0
434
4405
—
—
—
18
158
336
3639
Clinic/Center
261Q00000X [38004207]
261Q00000X [38004207]
1.0e+00
—
-1.0e+50
—
—
1.9e+00
—
cases:2.27%
controls:0.84%
—
—
cases:0.00%
controls:0.11%
—
—
—
—
cases:1.91%
controls:0.28%
—
—
10
37
431
4368
—
0
5
441
4400
—
—
8
12
410
4321
—
Cervicalgia
M54.2 [45591867]
M54.2 [45591867]
4.8e-01
—
—
—
—
—
1.9e+00
cases:1.13%
controls:0.70%
—
—
—
—
—
—
—
—
—
—
cases:4.24%
controls:0.63%
5
31
436
4374
—
—
—
—
—
15
24
339
3773
Anaemia other/unspecified
B82 [2002000293]
B82 [2002000293]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:1.98%
controls:0.29%
—
—
—
—
—
—
7
11
347
3786
Cathetrisation of artery
TPH07 [2001309747]
TPH07 [2001309747]
4.1e-01
-1.0e+50
—
—
—
1.9e+00
7.1e-01
cases:2.04%
controls:1.36%
cases:0.00%
controls:0.43%
—
—
—
—
—
—
cases:3.11%
controls:0.46%
cases:3.67%
controls:1.84%
9
60
432
4345
0
19
441
4386
—
—
—
13
20
405
4313
13
70
341
3727
propranolol; oral, parenteral
C07AA05 [21601670]
C07AA05 [21601670]
8.8e-01
1.1e+00
—
—
—
7.0e-01
4.5e-01
cases:7.71%
controls:3.36%
cases:4.99%
controls:1.79%
—
—
—
—
—
—
cases:3.83%
controls:1.94%
cases:6.21%
controls:4.06%
34
148
407
4257
22
79
419
4326
—
—
—
16
84
402
4249
22
154
332
3643
Melaena
K92.1 [45533624]
K92.1 [45533624]
9.2e-01
—
—
—
—
-1.0e+50
1.9e+00
cases:1.13%
controls:0.45%
—
—
—
—
—
—
—
—
cases:0.00%
controls:0.18%
cases:3.11%
controls:0.47%
5
20
436
4385
—
—
—
—
0
8
418
4325
11
18
343
3779
Endocrinology
46 [38004485]
46 [38004485]
5.7e-03
1.3e-01
1.2e+00
—
—
9.5e-01
9.5e-01
cases:3.40%
controls:3.38%
cases:2.27%
controls:2.00%
cases:1.13%
controls:0.34%
—
—
—
—
cases:4.31%
controls:1.71%
cases:8.47%
controls:3.45%
15
149
426
4256
10
88
431
4317
5
15
436
4390
—
—
18
74
400
4259
30
131
324
3666
Tissue transglutaminase IgA Ab [Units/volume] in Serum
31017-7 [3019050]
31017-7 [3019050]
7.5e-01
1.2e+00
—
—
—
—
3.7e-01
cases:6.12%
controls:3.00%
cases:4.54%
controls:1.48%
—
—
—
—
—
—
—
—
cases:6.78%
controls:4.79%
27
132
414
4273
20
65
421
4340
—
—
—
—
24
182
330
3615
cefalexin; oral
J01DB01 [21602870]
J01DB01 [21602870]
5.8e-01
5.4e-01
6.4e-01
—
8.6e-01
3.5e-01
7.6e-01
cases:41.50%
controls:28.33%
cases:14.29%
controls:8.83%
cases:2.27%
controls:1.20%
—
—
cases:2.49%
controls:1.07%
cases:12.68%
controls:9.32%
cases:43.50%
controls:26.42%
183
1248
258
3157
63
389
378
4016
10
53
431
4352
—
11
47
430
4353
53
404
365
3929
154
1003
200
2794
Fractional oxyhemoglobin in Arterial blood
2714-4 [3014007]
2714-4 [3014007]
7.8e-01
—
—
—
—
1.9e+00
8.0e-01
cases:1.81%
controls:0.84%
—
—
—
—
—
—
—
—
cases:2.39%
controls:0.37%
cases:3.95%
controls:1.82%
8
37
433
4368
—
—
—
—
10
16
408
4317
14
69
340
3728
hydroxocobalamin
V03AB33 [21605256]
V03AB33 [21605256]
6.1e-01
6.7e-01
—
—
—
9.6e-01
9.2e-01
cases:2.72%
controls:1.50%
cases:2.72%
controls:1.41%
—
—
—
—
—
—
cases:3.83%
controls:1.50%
cases:5.08%
controls:2.08%
12
66
429
4339
12
62
429
4343
—
—
—
16
65
402
4268
18
79
336
3718
hydroxocobalamin; parenteral
B03BA03 [21601123]
B03BA03 [21601123]
6.1e-01
6.7e-01
—
—
—
9.6e-01
9.2e-01
cases:2.72%
controls:1.50%
cases:2.72%
controls:1.41%
—
—
—
—
—
—
cases:3.83%
controls:1.50%
cases:5.08%
controls:2.08%
12
66
429
4339
12
62
429
4343
—
—
—
16
65
402
4268
18
79
336
3718
Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
46083-2 [3043362]
46083-2 [3043362]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.54%
controls:0.40%
—
—
—
—
—
—
9
15
345
3782
Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
46082-4 [3046524]
46082-4 [3046524]
—
—
—
—
—
—
1.9e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:2.54%
controls:0.40%
—
—
—
—
—
—
9
15
345
3782
Melanocytic naevi of trunk
D22.5 [45542688]
D22.5 [45542688]
1.9e+00
—
—
—
—
—
—
cases:2.04%
controls:0.32%
—
—
—
—
—
—
—
—
—
—
—
—
9
14
432
4391
—
—
—
—
—
—
Flexible bronchoscopy
UGC12 [2001303610]
UGC12 [2001303610]
8.4e-01
—
—
—
—
1.9e+00
6.9e-01
cases:1.81%
controls:0.79%
—
—
—
—
—
—
—
—
cases:1.91%
controls:0.30%
cases:1.41%
controls:0.71%
8
35
433
4370
—
—
—
—
8
13
410
4320
5
27
349
3770
Endomysium IgA Ab [Titer] in Serum
10863-9 [3020961]
10863-9 [3020961]
9.7e-01
1.9e+00
—
—
—
—
—
cases:1.36%
controls:0.52%
cases:1.59%
controls:0.25%
—
—
—
—
—
—
—
—
—
—
6
23
435
4382
7
11
434
4394
—
—
—
—
—
alfacalcidol; oral, parenteral
A11CC03 [21600818]
A11CC03 [21600818]
1.5e+00
—
—
—
—
2.2e+00
1.8e+00
cases:1.13%
controls:0.25%
—
—
—
—
—
—
—
—
cases:1.20%
controls:0.14%
cases:1.98%
controls:0.32%
5
11
436
4394
—
—
—
—
5
6
413
4327
7
12
347
3785
ciprofloxacin; oral, parenteral
J01MA02 [21603009]
J01MA02 [21603009]
6.0e-01
5.4e-01
—
—
—
1.2e+00
4.6e-01
cases:10.66%
controls:6.15%
cases:3.40%
controls:2.02%
—
—
—
—
—
—
cases:4.78%
controls:1.43%
cases:9.32%
controls:6.08%
47
271
394
4134
15
89
426
4316
—
—
—
20
62
398
4271
33
231
321
3566
Other specified special examinations
Z01.8 [45581003]
Z01.8 [45581003]
3.3e-01
1.8e+00
—
—
—
4.8e-01
4.6e-01
cases:3.85%
controls:2.81%
cases:5.22%
controls:0.89%
—
—
—
—
—
—
cases:1.67%
controls:1.04%
cases:5.37%
controls:3.45%
17
124
424
4281
23
39
418
4366
—
—
—
7
45
411
4288
19
131
335
3666
tinzaparin; parenteral
B01AB10 [21600981]
B01AB10 [21600981]
—
—
—
—
—
1.8e+00
5.0e-01
—
—
—
—
—
—
—
—
—
—
cases:1.91%
controls:0.32%
cases:2.82%
controls:1.74%
—
—
—
—
—
8
14
410
4319
10
66
344
3731
Lactate [Moles/volume] in Serum or Plasma
2524-7 [3014111]
2524-7 [3014111]
8.1e-01
—
—
—
—
1.8e+00
4.7e-01
cases:1.81%
controls:0.82%
—
—
—
—
—
—
—
—
cases:3.35%
controls:0.58%
cases:4.52%
controls:2.87%
8
36
433
4369
—
—
—
—
14
25
404
4308
16
109
338
3688
Nursing episode
950 [44777714]
950 [44777714]
2.4e-01
2.9e-01
—
—
1.8e+00
3.5e-01
-9.5e-02
cases:1.81%
controls:1.43%
cases:1.36%
controls:1.02%
—
—
—
—
cases:1.59%
controls:0.27%
cases:1.91%
controls:1.36%
cases:3.39%
controls:3.71%
8
63
433
4342
6
45
435
4360
—
—
7
12
434
4388
8
59
410
4274
12
141
342
3656
Shortness of breath/dyspnoea
R02 [2002000883]
R02 [2002000883]
3.3e-01
9.2e-01
—
—
—
1.8e+00
5.3e-01
cases:1.81%
controls:1.32%
cases:1.59%
controls:0.64%
—
—
—
—
—
—
cases:2.39%
controls:0.42%
cases:3.95%
controls:2.37%
8
58
433
4347
7
28
434
4377
—
—
—
10
18
408
4315
14
90
340
3707
salbutamol; inhalant
R03AC02 [21603256]
R03AC02 [21603256]
6.5e-01
6.0e-01
6.3e-01
—
6.3e-02
4.7e-01
4.8e-01
cases:24.26%
controls:14.37%
cases:13.61%
controls:7.95%
cases:2.49%
controls:1.34%
—
—
cases:1.81%
controls:1.70%
cases:12.68%
controls:8.33%
cases:25.14%
controls:17.17%
107
633
334
3772
60
350
381
4055
11
59
430
4346
—
8
75
433
4325
53
361
365
3972
89
652
265
3145
Acute bronchitis, unspecified
J20.9 [45562445]
J20.9 [45562445]
7.9e-01
3.9e-01
-1.0e+50
—
—
3.1e-01
9.3e-01
cases:5.44%
controls:2.54%
cases:1.13%
controls:0.77%
cases:0.00%
controls:0.11%
—
—
—
—
cases:1.44%
controls:1.06%
cases:7.06%
controls:2.92%
24
112
417
4293
5
34
436
4371
0
5
441
4400
—
—
6
46
412
4287
25
111
329
3686
Arthrocentesis, unspecified region, unspecified region
TNX10 [2001308560]
TNX10 [2001308560]
8.6e-01
—
—
—
—
—
1.7e+00
cases:1.81%
controls:0.77%
—
—
—
—
—
—
—
—
—
—
cases:2.54%
controls:0.47%
8
34
433
4371
—
—
—
—
—
9
18
345
3779
tramadol; oral, parenteral, rectal
N02AX02 [21604298]
N02AX02 [21604298]
4.9e-01
7.4e-01
7.7e-01
—
1.1e+00
9.5e-01
3.7e-01
cases:13.61%
controls:8.81%
cases:6.35%
controls:3.13%
cases:1.36%
controls:0.64%
—
—
cases:1.59%
controls:0.52%
cases:6.94%
controls:2.82%
cases:10.17%
controls:7.24%
60
388
381
4017
28
138
413
4267
6
28
435
4377
—
7
23
434
4377
29
122
389
4211
36
275
318
3522
Psychiatry
26 [38004469]
26 [38004469]
6.1e-01
5.6e-01
—
—
3.0e-01
9.0e-01
7.7e-01
cases:7.48%
controls:4.20%
cases:3.63%
controls:2.11%
—
—
—
—
cases:1.13%
controls:0.84%
cases:5.02%
controls:2.10%
cases:8.19%
controls:3.95%
33
185
408
4220
16
93
425
4312
—
—
5
37
436
4363
21
91
397
4242
29
150
325
3647
Rhinopharyngoscopy
UDH02 [2001301680]
UDH02 [2001301680]
1.7e+00
—
—
—
—
—
—
cases:3.17%
controls:0.61%
—
—
—
—
—
—
—
—
—
—
—
—
14
27
427
4378
—
—
—
—
—
—
Remote monitoring CPAP
WX780 [2001310837]
WX780 [2001310837]
—
-1.0e+50
—
—
—
—
1.7e+00
—
—
cases:0.00%
controls:0.18%
—
—
—
—
—
—
—
—
cases:2.82%
controls:0.55%
—
0
8
441
4397
—
—
—
—
10
21
344
3776
Recurrent depression, moderate episode without somatic syndrome
F33.10 [2000501984]
F33.10 [2000501984]
1.1e+00
—
—
—
—
—
1.6e+00
cases:1.13%
controls:0.36%
—
—
—
—
—
—
—
—
—
—
cases:2.54%
controls:0.50%
5
16
436
4389
—
—
—
—
—
9
19
345
3778
doxycycline; oral, parenteral
J01AA02 [21602800]
J01AA02 [21602800]
3.9e-01
2.0e-01
—
—
—
7.0e-01
5.4e-01
cases:25.62%
controls:18.91%
cases:6.80%
controls:5.65%
—
—
—
—
—
—
cases:9.81%
controls:5.10%
cases:24.86%
controls:16.12%
113
833
328
3572
30
249
411
4156
—
—
—
41
221
377
4112
88
612
266
3185
Protein [Mass/volume] in Serum or Plasma
2885-2 [3020630]
2885-2 [3020630]
6.7e-01
1.3e+00
—
—
—
1.6e+00
6.7e-01
cases:2.49%
controls:1.29%
cases:2.04%
controls:0.59%
—
—
—
—
—
—
cases:3.11%
controls:0.62%
cases:4.24%
controls:2.21%
11
57
430
4348
9
26
432
4379
—
—
—
13
27
405
4306
15
84
339
3713
triamcinolone and antiinfectives
S02CA04 [21605176]
S02CA04 [21605176]
1.6e+00
—
—
—
—
—
9.0e-01
cases:2.27%
controls:0.45%
—
—
—
—
—
—
—
—
—
—
cases:1.41%
controls:0.58%
10
20
431
4385
—
—
—
—
—
5
22
349
3775
Bacteria [Presence] in Urine
87829-8 [36304419]
87829-8 [36304419]
3.4e-02
5.3e-01
1.6e+00
—
9.2e-01
7.7e-01
5.0e-01
cases:4.76%
controls:4.61%
cases:4.31%
controls:2.59%
cases:1.81%
controls:0.36%
—
—
cases:1.13%
controls:0.45%
cases:5.02%
controls:2.40%
cases:12.71%
controls:8.11%
21
203
420
4202
19
114
422
4291
8
16
433
4389
—
5
20
436
4380
21
104
397
4229
45
308
309
3489
Casts [#/volume] in Urine by Automated count
51483-6 [3030467]
51483-6 [3030467]
6.3e-02
4.6e-01
1.6e+00
—
9.2e-01
6.9e-01
3.6e-01
cases:4.99%
controls:4.70%
cases:4.31%
controls:2.77%
cases:1.81%
controls:0.36%
—
—
cases:1.13%
controls:0.45%
cases:5.26%
controls:2.72%
cases:12.15%
controls:8.82%
22
207
419
4198
19
122
422
4283
8
16
433
4389
—
5
20
436
4380
22
118
396
4215
43
335
311
3462
pregabalin; oral
N02BF02 [955152]
N02BF02 [955152]
5.5e-01
7.5e-01
1.0e+00
—
8.9e-01
9.3e-01
6.8e-01
cases:8.39%
controls:5.02%
cases:4.76%
controls:2.32%
cases:2.04%
controls:0.75%
—
—
cases:1.81%
controls:0.75%
cases:5.74%
controls:2.35%
cases:10.17%
controls:5.43%
37
221
404
4184
21
102
420
4303
9
33
432
4372
—
8
33
433
4367
24
102
394
4231
36
206
318
3591
furosemide; oral, parenteral
C03CA01 [21601518]
C03CA01 [21601518]
6.4e-01
5.5e-01
8.2e-01
—
9.5e-01
5.6e-01
4.1e-01
cases:12.93%
controls:7.24%
cases:10.20%
controls:6.15%
cases:3.40%
controls:1.52%
—
—
cases:4.31%
controls:1.70%
cases:10.77%
controls:6.44%
cases:14.97%
controls:10.46%
57
319
384
4086
45
271
396
4134
15
67
426
4338
—
19
75
422
4325
45
279
373
4054
53
397
301
3400
Calcium [Moles/volume] corrected for albumin in Serum or Plasma
29265-6 [3020059]
29265-6 [3020059]
3.0e-01
4.1e-01
-1.0e+50
—
—
8.9e-01
7.0e-01
cases:4.08%
controls:3.06%
cases:2.04%
controls:1.36%
cases:0.00%
controls:0.20%
—
—
—
—
cases:4.55%
controls:1.92%
cases:10.73%
controls:5.61%
18
135
423
4270
9
60
432
4345
0
9
441
4396
—
—
19
83
399
4250
38
213
316
3584
Helicobacter pylori Ab [Units/volume] in Serum
7900-4 [3017895]
7900-4 [3017895]
1.2e+00
—
1.0e+50
—
—
—
1.6e+00
cases:1.81%
controls:0.57%
—
—
cases:1.13%
controls:0.00%
—
—
—
—
—
—
cases:2.54%
controls:0.53%
8
25
433
4380
—
5
0
436
4405
—
—
—
9
20
345
3777
Flexible laryngoscopy
UDQ12 [2001301827]
UDQ12 [2001301827]
6.6e-01
—
—
—
—
1.7e+00
1.6e+00
cases:1.13%
controls:0.59%
—
—
—
—
—
—
—
—
cases:1.67%
controls:0.30%
cases:2.54%
controls:0.53%
5
26
436
4379
—
—
—
—
7
13
411
4320
9
20
345
3777
Leukocytes [#/volume] in Urine
30405-5 [3018095]
30405-5 [3018095]
1.3e-01
3.1e-01
1.6e+00
—
1.1e+00
5.1e-01
3.0e-01
cases:7.03%
controls:6.20%
cases:5.22%
controls:3.88%
cases:2.04%
controls:0.43%
—
—
cases:1.81%
controls:0.59%
cases:6.22%
controls:3.83%
cases:15.25%
controls:11.80%
31
273
410
4132
23
171
418
4234
9
19
432
4386
—
8
26
433
4374
26
166
392
4167
54
448
300
3349
Bacteria identified in Isolate by Culture
43409-2 [3042936]
43409-2 [3042936]
4.5e-01
2.2e-01
—
—
-1.0e+50
1.5e+00
6.8e-01
cases:3.40%
controls:2.20%
cases:1.36%
controls:1.09%
—
—
—
—
cases:0.00%
controls:0.16%
cases:3.59%
controls:0.78%
cases:7.91%
controls:4.16%
15
97
426
4308
6
48
435
4357
—
—
0
7
441
4393
15
34
403
4299
28
158
326
3639
Hemoglobin [Mass/volume] in Arterial blood
30313-1 [3002173]
30313-1 [3002173]
3.1e-01
—
—
—
-1.0e+50
1.5e+00
4.6e-01
cases:1.81%
controls:1.34%
—
—
—
—
—
—
cases:0.00%
controls:0.11%
cases:2.63%
controls:0.58%
cases:5.08%
controls:3.27%
8
59
433
4346
—
—
—
0
5
441
4395
11
25
407
4308
18
124
336
3673
Erythrocytes [#/volume] in Urine
30391-7 [3002582]
30391-7 [3002582]
2.5e-02
2.7e-01
1.5e+00
—
9.6e-01
6.0e-01
2.2e-01
cases:5.67%
controls:5.54%
cases:4.31%
controls:3.34%
cases:2.04%
controls:0.45%
—
—
cases:1.36%
controls:0.52%
cases:5.50%
controls:3.09%
cases:12.43%
controls:10.22%
25
244
416
4161
19
147
422
4258
9
20
432
4385
—
6
23
435
4377
23
134
395
4199
44
388
310
3409
Ambulatory ECG
XF404 [2001303370]
XF404 [2001303370]
2.0e-01
—
—
—
—
—
1.5e+00
cases:1.36%
controls:1.11%
—
—
—
—
—
—
—
—
—
—
cases:3.95%
controls:0.90%
6
49
435
4356
—
—
—
—
—
14
34
340
3763
Oxygen saturation in Arterial blood
2708-6 [3016502]
2708-6 [3016502]
2.6e-01
—
—
—
—
1.5e+00
4.7e-01
cases:1.81%
controls:1.41%
—
—
—
—
—
—
—
—
cases:2.63%
controls:0.60%
cases:5.08%
controls:3.24%
8
62
433
4343
—
—
—
—
11
26
407
4307
18
123
336
3674
ECG with 12 standard connections
XF400 [2001303368]
XF400 [2001303368]
7.4e-01
1.5e+00
—
—
—
1.1e+00
9.3e-01
cases:3.85%
controls:1.88%
cases:3.40%
controls:0.79%
—
—
—
—
—
—
cases:1.67%
controls:0.58%
cases:3.67%
controls:1.47%
17
83
424
4322
15
35
426
4370
—
—
—
7
25
411
4308
13
56
341
3741
Acute sinusitis
J01 [45548098]
J01 [45548098]
1.5e+00
-1.0e+50
—
—
—
—
—
cases:2.04%
controls:0.48%
cases:0.00%
controls:0.23%
—
—
—
—
—
—
—
—
—
—
9
21
432
4384
0
10
441
4395
—
—
—
—
—
Clinical & Laboratory Dermatological Immunology Physician
207NI0002X [38003841]
207NI0002X [38003841]
6.1e-01
6.1e-01
1.2e+00
—
4.2e-01
6.9e-01
8.2e-01
cases:11.79%
controls:6.77%
cases:6.58%
controls:3.70%
cases:1.36%
controls:0.41%
—
—
cases:1.13%
controls:0.75%
cases:6.22%
controls:3.23%
cases:16.38%
controls:7.95%
52
298
389
4107
29
163
412
4242
6
18
435
4387
—
5
33
436
4367
26
140
392
4193
58
302
296
3495
Back symptom/complaint
L02 [2002000627]
L02 [2002000627]
1.4e+00
—
—
—
—
—
5.1e-02
cases:2.95%
controls:0.73%
—
—
—
—
—
—
—
—
—
—
cases:1.41%
controls:1.34%
13
32
428
4373
—
—
—
—
—
5
51
349
3746
Cancer Ag 125 [Units/volume] in Serum or Plasma
10334-1 [3037551]
10334-1 [3037551]
—
8.3e-01
—
—
—
1.4e+00
1.4e+00
—
—
cases:1.13%
controls:0.50%
—
—
—
—
—
—
cases:1.44%
controls:0.37%
cases:3.39%
controls:0.84%
—
5
22
436
4383
—
—
—
6
16
412
4317
12
32
342
3765
Throat symptom/complaint
R21 [2002000891]
R21 [2002000891]
2.3e-01
1.4e+00
—
—
—
—
6.9e-01
cases:2.95%
controls:2.36%
cases:3.17%
controls:0.79%
—
—
—
—
—
—
—
—
cases:3.95%
controls:2.03%
13
104
428
4301
14
35
427
4370
—
—
—
—
14
77
340
3720
paracetamol; oral, parenteral, rectal
N02BE01 [21604344]
N02BE01 [21604344]
2.4e-01
4.6e-01
1.2e-01
—
2.8e-01
5.3e-01
4.2e-01
cases:41.72%
controls:36.12%
cases:28.34%
controls:20.02%
cases:4.54%
controls:4.04%
—
—
cases:5.22%
controls:4.00%
cases:31.34%
controls:21.23%
cases:54.52%
controls:44.17%
184
1591
257
2814
125
882
316
3523
20
178
421
4227
—
23
176
418
4224
131
920
287
3413
193
1677
161
2120
Other obesity
E66.8 [45533036]
E66.8 [45533036]
1.0e+00
9.7e-01
—
—
—
1.2e+00
1.4e+00
cases:1.59%
controls:0.59%
cases:1.36%
controls:0.52%
—
—
—
—
—
—
cases:1.20%
controls:0.35%
cases:3.39%
controls:0.87%
7
26
434
4379
6
23
435
4382
—
—
—
5
15
413
4318
12
33
342
3764
Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
546-2 [3024135]
546-2 [3024135]
4.3e-01
1.4e+00
—
—
—
4.0e-01
4.4e-01
cases:3.85%
controls:2.54%
cases:2.72%
controls:0.70%
—
—
—
—
—
—
cases:1.20%
controls:0.81%
cases:5.08%
controls:3.34%
17
112
424
4293
12
31
429
4374
—
—
—
5
35
413
4298
18
127
336
3670
Trichilemmal cyst
L72.1 [45596386]
L72.1 [45596386]
7.4e-01
—
—
—
—
—
1.4e+00
cases:1.13%
controls:0.54%
—
—
—
—
—
—
—
—
—
—
cases:3.11%
controls:0.82%
5
24
436
4381
—
—
—
—
—
11
31
343
3766
Hepatitis C virus Ab [Presence] in Serum
16128-1 [3017143]
16128-1 [3017143]
7.9e-01
1.4e+00
—
—
-1.0e+50
8.8e-01
9.1e-01
cases:3.63%
controls:1.68%
cases:2.49%
controls:0.66%
—
—
—
—
cases:0.00%
controls:0.14%
cases:1.44%
controls:0.60%
cases:3.95%
controls:1.63%
16
74
425
4331
11
29
430
4376
—
—
0
6
441
4394
6
26
412
4307
14
62
340
3735
Carbon dioxide [Partial pressure] in Venous blood
2021-4 [3021447]
2021-4 [3021447]
1.2e+00
3.9e-01
—
—
—
1.3e+00
2.0e-01
cases:2.49%
controls:0.77%
cases:1.13%
controls:0.77%
—
—
—
—
—
—
cases:2.87%
controls:0.76%
cases:4.52%
controls:3.71%
11
34
430
4371
5
34
436
4371
—
—
—
12
33
406
4300
16
141
338
3656
Other specified intervertebral disc degeneration
M51.3 [45591865]
M51.3 [45591865]
6.8e-01
1.2e+00
—
—
—
—
1.3e+00
cases:2.04%
controls:1.04%
cases:1.13%
controls:0.34%
—
—
—
—
—
—
—
—
cases:3.67%
controls:1.00%
9
46
432
4359
5
15
436
4390
—
—
—
—
13
38
341
3759
Hepatitis B virus surface Ag [Presence] in Serum
5195-3 [3019284]
5195-3 [3019284]
6.5e-01
1.3e+00
—
—
—
8.4e-01
7.5e-01
cases:3.63%
controls:1.93%
cases:2.49%
controls:0.68%
—
—
—
—
—
—
cases:1.44%
controls:0.62%
cases:4.24%
controls:2.05%
16
85
425
4320
11
30
430
4375
—
—
—
6
27
412
4306
15
78
339
3719
Lumbar spine MRI examination with high intensity magnet
NA3BG [2001307034]
NA3BG [2001307034]
6.6e-01
—
—
—
—
1.2e+00
1.3e+00
cases:2.27%
controls:1.18%
—
—
—
—
—
—
—
—
cases:1.20%
controls:0.35%
cases:3.67%
controls:1.03%
10
52
431
4353
—
—
—
—
5
15
413
4318
13
39
341
3758
Other spondylosis with radiculopathy
M47.2 [45591850]
M47.2 [45591850]
3.8e-01
—
—
—
—
—
1.3e+00
cases:1.36%
controls:0.93%
—
—
—
—
—
—
—
—
—
—
cases:3.39%
controls:0.95%
6
41
435
4364
—
—
—
—
—
12
36
342
3761
Monitored bed care
WX892 [2001310850]
WX892 [2001310850]
7.0e-01
—
—
1.0e+50
—
—
1.3e+00
cases:1.36%
controls:0.68%
—
—
—
—
cases:1.13%
controls:0.00%
—
—
—
—
cases:3.11%
controls:0.87%
6
30
435
4375
—
—
5
0
436
4405
—
—
11
33
343
3764
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
LC2BE [2001306544]
LC2BE [2001306544]
5.7e-01
5.5e-01
—
—
—
1.3e+00
8.0e-01
cases:6.12%
controls:3.54%
cases:2.27%
controls:1.32%
—
—
—
—
—
—
cases:2.63%
controls:0.74%
cases:5.93%
controls:2.77%
27
156
414
4249
10
58
431
4347
—
—
—
11
32
407
4301
21
105
333
3692
Base excess in Arterial blood by calculation
1925-7 [3003396]
1925-7 [3003396]
3.3e-01
—
—
—
—
1.3e+00
3.3e-01
cases:2.27%
controls:1.63%
—
—
—
—
—
—
—
—
cases:2.63%
controls:0.74%
cases:5.08%
controls:3.71%
10
72
431
4333
—
—
—
—
11
32
407
4301
18
141
336
3656
Base excess in Venous blood by calculation
1927-3 [3002032]
1927-3 [3002032]
1.3e+00
3.6e-01
—
—
—
1.3e+00
9.5e-02
cases:2.49%
controls:0.73%
cases:1.13%
controls:0.79%
—
—
—
—
—
—
cases:2.87%
controls:0.81%
cases:3.95%
controls:3.61%
11
32
430
4373
5
35
436
4370
—
—
—
12
35
406
4298
14
137
340
3660
ranitidine bismuth citrate; oral
A02BA07 [21600088]
A02BA07 [21600088]
6.6e-01
1.3e+00
—
—
—
8.2e-01
1.3e+00
cases:4.08%
controls:2.16%
cases:2.04%
controls:0.54%
—
—
—
—
—
—
cases:1.20%
controls:0.53%
cases:3.39%
controls:0.97%
18
95
423
4310
9
24
432
4381
—
—
—
5
23
413
4310
12
37
342
3760
ranitidine; oral, parenteral
A02BA02 [21600083]
A02BA02 [21600083]
6.6e-01
1.3e+00
—
—
—
8.2e-01
1.3e+00
cases:4.08%
controls:2.16%
cases:2.04%
controls:0.54%
—
—
—
—
—
—
cases:1.20%
controls:0.53%
cases:3.39%
controls:0.97%
18
95
423
4310
9
24
432
4381
—
—
—
5
23
413
4310
12
37
342
3760
Foot and toes X-ray examination
NH3AA [2001308267]
NH3AA [2001308267]
4.7e-01
—
—
—
—
—
1.3e+00
cases:1.59%
controls:1.00%
—
—
—
—
—
—
—
—
—
—
cases:3.39%
controls:0.97%
7
44
434
4361
—
—
—
—
—
12
37
342
3760
More than three and less than five hours
ZXE20 [2001311408]
ZXE20 [2001311408]
3.3e-01
—
—
—
—
1.9e+00
1.3e+00
cases:2.72%
controls:1.98%
—
—
—
—
—
—
—
—
cases:1.44%
controls:0.21%
cases:3.67%
controls:1.08%
12
87
429
4318
—
—
—
—
6
9
412
4324
13
41
341
3756
pH of Venous blood
2746-6 [3012544]
2746-6 [3012544]
1.2e+00
4.2e-01
—
—
—
1.2e+00
8.8e-02
cases:2.72%
controls:0.84%
cases:1.13%
controls:0.75%
—
—
—
—
—
—
cases:2.87%
controls:0.85%
cases:3.95%
controls:3.63%
12
37
429
4368
5
33
436
4372
—
—
—
12
37
406
4296
14
138
340
3659
prednisolone
A07EA01 [21600653]
A07EA01 [21600653]
6.4e-01
5.0e-01
9.9e-01
—
7.5e-01
5.3e-01
5.7e-01
cases:19.05%
controls:11.06%
cases:8.62%
controls:5.40%
cases:2.95%
controls:1.11%
—
—
cases:1.81%
controls:0.86%
cases:10.05%
controls:6.16%
cases:21.19%
controls:13.14%
84
487
357
3918
38
238
403
4167
13
49
428
4356
—
8
38
433
4362
42
267
376
4066
75
499
279
3298
Reticulocytes [#/volume] in Blood
14196-0 [3023520]
14196-0 [3023520]
1.2e+00
7.9e-01
—
—
—
8.8e-01
6.0e-01
cases:3.17%
controls:0.98%
cases:1.59%
controls:0.73%
—
—
—
—
—
—
cases:1.44%
controls:0.60%
cases:4.24%
controls:2.37%
14
43
427
4362
7
32
434
4373
—
—
—
6
26
412
4307
15
90
339
3707
Emergency Medicine
93 [38004510]
93 [38004510]
2.4e-01
5.3e-01
1.2e+00
—
1.0e+00
4.1e-01
2.1e-01
cases:14.74%
controls:11.96%
cases:10.43%
controls:6.40%
cases:2.95%
controls:0.91%
—
—
cases:2.95%
controls:1.07%
cases:10.77%
controls:7.41%
cases:26.27%
controls:22.36%
65
527
376
3878
46
282
395
4123
13
40
428
4365
—
13
47
428
4353
45
321
373
4012
93
849
261
2948
prednisolone; oral, parenteral
H02AB06 [21602734]
H02AB06 [21602734]
6.3e-01
5.1e-01
9.9e-01
—
7.5e-01
5.4e-01
5.7e-01
cases:18.82%
controls:10.99%
cases:8.62%
controls:5.36%
cases:2.95%
controls:1.11%
—
—
cases:1.81%
controls:0.86%
cases:10.05%
controls:6.12%
cases:20.90%
controls:13.04%
83
484
358
3921
38
236
403
4169
13
49
428
4356
—
8
38
433
4362
42
265
376
4068
74
495
280
3302
Abdominal ultrasound examination
JN3AE [2001305555]
JN3AE [2001305555]
8.0e-01
—
—
—
—
—
1.2e+00
cases:4.08%
controls:1.88%
—
—
—
—
—
—
—
—
—
—
cases:4.80%
controls:1.50%
18
83
423
4322
—
—
—
—
—
17
57
337
3740
dexamethasone; oral, parenteral
H02AB02 [21602730]
H02AB02 [21602730]
-1.6e-01
—
—
—
—
1.2e+00
3.2e-01
cases:2.04%
controls:2.38%
—
—
—
—
—
—
—
—
cases:3.59%
controls:1.13%
cases:3.95%
controls:2.90%
9
105
432
4300
—
—
—
—
15
49
403
4284
14
110
340
3687
Headache
N01 [2002000720]
N01 [2002000720]
5.2e-01
—
—
—
—
—
1.2e+00
cases:1.36%
controls:0.82%
—
—
—
—
—
—
—
—
—
—
cases:3.67%
controls:1.16%
6
36
435
4369
—
—
—
—
—
13
44
341
3753
Obesity due to excess calories
E66.01 [2000501501]
E66.01 [2000501501]
9.5e-01
1.2e+00
—
—
—
1.1e+00
1.2e+00
cases:2.72%
controls:1.07%
cases:1.81%
controls:0.57%
—
—
—
—
—
—
cases:1.67%
controls:0.55%
cases:4.24%
controls:1.37%
12
47
429
4358
8
25
433
4380
—
—
—
7
24
411
4309
15
52
339
3745
Haptoglobin [Mass/volume] in Serum or Plasma
4542-7 [3012336]
4542-7 [3012336]
1.0e+00
1.4e+00
—
—
—
—
1.1e+00
cases:1.59%
controls:0.57%
cases:1.13%
controls:0.30%
—
—
—
—
—
—
—
—
cases:3.67%
controls:1.21%
7
25
434
4380
5
13
436
4392
—
—
—
—
13
46
341
3751
Urinalysis macro (dipstick) panel - Urine
24357-6 [3037467]
24357-6 [3037467]
2.9e-01
4.0e-01
1.1e+00
—
6.2e-01
2.0e-01
3.2e-01
cases:19.50%
controls:15.32%
cases:12.93%
controls:9.04%
cases:3.17%
controls:1.04%
—
—
cases:2.49%
controls:1.36%
cases:10.77%
controls:8.95%
cases:30.79%
controls:24.36%
86
675
355
3730
57
398
384
4007
14
46
427
4359
—
11
60
430
4340
45
388
373
3945
109
925
245
2872
Unspecified haematuria
R31 [45553726]
R31 [45553726]
—
—
-1.0e+50
—
—
—
1.1e+00
—
—
—
—
cases:0.00%
controls:0.14%
—
—
—
—
—
—
cases:3.95%
controls:1.32%
—
—
0
6
441
4399
—
—
—
14
50
340
3747
Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
1805-1 [3016417]
1805-1 [3016417]
8.9e-01
1.0e+00
1.8e+00
—
—
1.2e+00
1.1e+00
cases:3.63%
controls:1.52%
cases:2.04%
controls:0.73%
cases:1.13%
controls:0.18%
—
—
—
—
cases:2.39%
controls:0.76%
cases:5.93%
controls:2.03%
16
67
425
4338
9
32
432
4373
5
8
436
4397
—
—
10
33
408
4300
21
77
333
3720
Pain in joint
M25.5 [45586941]
M25.5 [45586941]
2.7e-01
1.1e+00
-1.0e+50
—
—
-2.4e-01
1.9e-01
cases:5.44%
controls:4.22%
cases:3.63%
controls:1.23%
cases:0.00%
controls:0.20%
—
—
—
—
cases:1.20%
controls:1.52%
cases:6.21%
controls:5.21%
24
186
417
4219
16
54
425
4351
0
9
441
4396
—
—
5
66
413
4267
22
198
332
3599
Folate [Moles/volume] in Serum or Plasma
14732-2 [3021960]
14732-2 [3021960]
5.5e-01
7.9e-01
—
—
—
1.1e+00
2.6e-01
cases:3.63%
controls:2.13%
cases:3.40%
controls:1.57%
—
—
—
—
—
—
cases:5.26%
controls:1.82%
cases:11.30%
controls:8.95%
16
94
425
4311
15
69
426
4336
—
—
—
22
79
396
4254
40
340
314
3457
Electrocardiogram with exercise test
46136006 [4261794]
46136006 [4261794]
5.9e-01
—
—
—
—
—
1.1e+00
cases:2.72%
controls:1.52%
—
—
—
—
—
—
—
—
—
—
cases:3.67%
controls:1.26%
12
67
429
4338
—
—
—
—
—
13
48
341
3749
calcium (different salts in combination); oral
A12AA20 [21600872]
A12AA20 [21600872]
2.8e-01
4.6e-01
5.3e-01
—
2.4e-01
5.7e-01
5.2e-01
cases:12.93%
controls:10.06%
cases:12.24%
controls:8.08%
cases:2.95%
controls:1.75%
—
—
cases:2.95%
controls:2.34%
cases:14.11%
controls:8.54%
cases:19.21%
controls:12.38%
57
443
384
3962
54
356
387
4049
13
77
428
4328
—
13
103
428
4297
59
370
359
3963
68
470
286
3327
codeine and paracetamol
N02AJ06 [1123647]
N02AJ06 [1123647]
3.3e-01
4.0e-01
3.4e-01
—
3.5e-01
5.8e-01
4.8e-01
cases:19.50%
controls:14.89%
cases:9.52%
controls:6.56%
cases:1.81%
controls:1.29%
—
—
cases:2.27%
controls:1.61%
cases:11.00%
controls:6.46%
cases:23.73%
controls:16.20%
86
656
355
3749
42
289
399
4116
8
57
433
4348
—
10
71
431
4329
46
280
372
4053
84
615
270
3182
Chronic asthma and similar chronic obstructive pulmonary diseases
203 [2001600201]
203 [2001600201]
1.1e+00
—
—
—
—
—
4.8e-01
cases:4.31%
controls:1.54%
—
—
—
—
—
—
—
—
—
—
cases:1.98%
controls:1.24%
19
68
422
4337
—
—
—
—
—
7
47
347
3750
Headache
R51.80 [2000503603]
R51.80 [2000503603]
7.8e-02
4.2e-01
—
—
—
—
1.0e+00
cases:1.81%
controls:1.68%
cases:1.13%
controls:0.75%
—
—
—
—
—
—
—
—
cases:5.37%
controls:1.95%
8
74
433
4331
5
33
436
4372
—
—
—
—
19
74
335
3723
Chest pain, unspecified
R07.4 [45558450]
R07.4 [45558450]
4.1e-01
5.5e-01
—
—
—
1.0e+00
5.8e-01
cases:6.12%
controls:4.13%
cases:2.49%
controls:1.45%
—
—
—
—
—
—
cases:3.35%
controls:1.20%
cases:8.76%
controls:5.11%
27
182
414
4223
11
64
430
4341
—
—
—
14
52
404
4281
31
194
323
3603
IgE [Units/volume] in Serum or Plasma
19113-0 [3005322]
19113-0 [3005322]
—
—
—
—
—
—
1.0e+00
—
—
—
—
—
—
—
—
—
—
—
—
cases:3.95%
controls:1.45%
—
—
—
—
—
—
14
55
340
3742
Other specified chronic obstructive pulmonary disease
J44.8 [45586673]
J44.8 [45586673]
7.2e-01
9.3e-01
—
—
1.5e+00
1.0e+00
8.4e-01
cases:3.40%
controls:1.68%
cases:2.27%
controls:0.91%
—
—
—
—
cases:1.36%
controls:0.30%
cases:3.59%
controls:1.32%
cases:5.37%
controls:2.40%
15
74
426
4331
10
40
431
4365
—
—
6
13
435
4387
15
57
403
4276
19
91
335
3706
Bacteria identified in Blood by Culture
600-7 [3023368]
600-7 [3023368]
4.7e-01
7.7e-01
1.6e+00
—
1.6e+00
1.0e+00
5.1e-01
cases:6.35%
controls:4.06%
cases:4.31%
controls:2.04%
cases:1.59%
controls:0.32%
—
—
cases:1.36%
controls:0.27%
cases:5.98%
controls:2.24%
cases:13.84%
controls:8.82%
28
179
413
4226
19
90
422
4315
7
14
434
4391
—
6
12
435
4388
25
97
393
4236
49
335
305
3462
hydroxyzine; oral, parenteral
N05BB01 [21604590]
N05BB01 [21604590]
3.9e-01
4.8e-01
-1.0e+50
—
—
—
1.0e+00
cases:2.49%
controls:1.70%
cases:1.13%
controls:0.70%
cases:0.00%
controls:0.11%
—
—
—
—
—
—
cases:5.08%
controls:1.92%
11
75
430
4330
5
31
436
4374
0
5
441
4400
—
—
—
18
73
336
3724
Parathyrin.intact [Mass/volume] in Serum or Plasma
2731-8 [3000067]
2731-8 [3000067]
-6.7e-02
7.0e-01
—
—
—
1.2e+00
9.9e-01
cases:1.36%
controls:1.45%
cases:1.81%
controls:0.91%
—
—
—
—
—
—
cases:2.39%
controls:0.76%
cases:5.65%
controls:2.19%
6
64
435
4341
8
40
433
4365
—
—
—
10
33
408
4300
20
83
334
3714
zolpidem; oral
N05CF02 [21604655]
N05CF02 [21604655]
4.5e-01
5.5e-01
—
—
1.2e+00
9.8e-01
3.7e-01
cases:5.22%
controls:3.41%
cases:3.63%
controls:2.13%
—
—
—
—
cases:1.13%
controls:0.34%
cases:5.02%
controls:1.94%
cases:5.08%
controls:3.58%
23
150
418
4255
16
94
425
4311
—
—
5
15
436
4385
21
84
397
4249
18
136
336
3661
Pain localized to other parts of lower abdomen
R10.3 [45534426]
R10.3 [45534426]
7.8e-01
1.0e+00
—
—
-1.0e+50
8.1e-01
9.8e-01
cases:5.22%
controls:2.45%
cases:2.04%
controls:0.73%
—
—
—
—
cases:0.00%
controls:0.14%
cases:2.15%
controls:0.97%
cases:7.91%
controls:3.13%
23
108
418
4297
9
32
432
4373
—
—
0
6
441
4394
9
42
409
4291
28
119
326
3678
clarithromycin; oral, parenteral
J01FA09 [21602977]
J01FA09 [21602977]
2.7e-01
8.2e-01
—
—
—
—
9.7e-01
cases:4.31%
controls:3.34%
cases:1.59%
controls:0.70%
—
—
—
—
—
—
—
—
cases:4.80%
controls:1.87%
19
147
422
4258
7
31
434
4374
—
—
—
—
17
71
337
3726
Other gastroenteritis and colitis of infectious and unspecified origin
A09 [45605189]
A09 [45605189]
8.1e-01
1.3e+00
—
—
—
4.0e-01
9.7e-01
cases:4.54%
controls:2.07%
cases:2.27%
controls:0.64%
—
—
—
—
—
—
cases:1.20%
controls:0.81%
cases:5.65%
controls:2.21%
20
91
421
4314
10
28
431
4377
—
—
—
5
35
413
4298
20
84
334
3713
LabWAS
↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
289
1814
2.68
21.77
8.4
5.1
35.25
35.57
g/l
0.45
278
1709
325
2191
2.77
20.70
8.6
6.9
10.99
11.31
umol/l
0.24
312
2086
104
398
3.10
20.60
3.1
2.5
0.21
0.21
g/l
0.23
96
372
199
1075
2.53
20.10
3.0
2.1
2.82
3.01
mg/l
0.54
178
932
221
1302
2.38
17.87
3.4
2.6
54.55
124.68
u/l
0.60
203
1212
394
3054
3.45
17.38
11.9
8.5
82.16
79.80
u/l
0.34
375
2887
290
1975
2.33
16.05
19.4
14.5
1.25
1.25
inr
0.00
236
1629
299
2087
2.31
15.25
13.5
7.1
1.21
1.21
mmol/l
0.15
264
1803
278
1893
2.24
14.92
12.7
6.3
1.21
1.21
mmol/l
0.13
256
1745
116
548
2.51
14.92
11.8
5.9
1.05
1.03
mmol/l
0.51
110
502
321
2375
2.25
13.25
10.5
5.0
6.78
6.75
mmol/l
0.10
304
2261
130
701
2.20
12.04
4.0
2.5
10.79
13.11
umol/l
3.47
123
655
84
380
2.49
11.63
2.7
2.5
37.25
31.59
u/l
0.61
63
319
302
2244
2.07
11.45
12.7
10.2
4.38
4.13
e9/l
0.96
259
1957
259
1825
2.00
11.38
4.6
3.0
114.46
131.56
ug/l
0.62
243
1687
96
472
2.32
11.00
3.6
3.1
6.22
8.48
umol/l
0.94
82
424
78
361
2.41
10.21
14.1
7.9
9.73
10.03
mmol/l
0.12
72
347
97
495
2.23
10.11
16.3
7.4
0.78
0.87
mmol/l
0.06
81
413
255
1834
1.91
10.04
2.6
2.2
97.38
95.49
pmol/l
0.26
153
973
68
300
2.49
9.86
3.2
3.4
208.92
214.12
ng/l
0.04
62
272
98
512
2.17
9.60
16.3
7.2
5.02
5.14
kpa
0.54
92
492
98
512
2.17
9.60
16.3
7.2
12.36
12.20
kpa
0.09
92
493
251
1818
1.87
9.45
4.4
2.8
—
—
estimate
—
0
0
154
959
1.92
9.25
4.7
2.4
—
—
—
0
0
41
150
2.91
8.54
1.7
1.6
19.24
11.41
u/ml
—
5
25
195
1336
1.82
8.51
4.8
3.5
28.50
31.25
u/l
1.16
184
1263
64
298
2.34
8.21
1.9
1.7
—
—
—
0
0
351
2914
1.95
7.76
5.6
4.4
14.76
12.23
mm/h
1.87
322
2703
65
312
2.27
7.76
5.2
3.6
111.14
82.90
ng/l
1.35
56
272
131
816
1.86
7.64
4.7
4.0
565.88
299.79
ng/l
0.25
101
658
319
2582
1.82
7.48
4.7
3.4
60.03
51.25
u/l
0.58
290
2414
86
474
2.01
7.18
2.9
4.6
7.54
36.43
ug/l
1.00
77
398
23
70
3.41
6.50
1.5
1.5
—
—
—
0
0
23
70
3.41
6.50
1.5
1.5
—
—
—
0
0
416
3747
2.59
6.47
31.1
16.8
24.75
24.19
mg/l
0.14
369
3088
41
185
2.34
5.64
2.0
1.7
1.37
1.49
g/l
0.41
35
166
173
1250
1.63
5.62
2.1
1.7
21.05
20.97
nmol/l
0.03
154
1040
60
320
2.01
5.45
1.6
1.5
—
—
—
0
0
72
415
1.88
5.21
4.5
4.0
1.51
1.91
mmol/l
0.32
67
356
161
1167
1.59
5.05
4.4
3.4
0.32
0.46
e6/l
0.74
119
858
25
94
2.76
5.00
1.5
1.4
—
—
—
0
0
190
1435
1.56
4.98
3.9
3.6
2.34
2.35
mmol/l
0.53
174
1295
225
1768
1.55
4.92
3.2
2.5
73.96
77.68
nmol/l
1.33
199
1573
109
728
1.66
4.72
2.0
1.7
1140.30
1190.97
nmol/l
0.19
80
547
31
135
2.39
4.64
1.6
1.4
329.45
288.26
ug/g
0.59
26
79
389
3511
1.83
4.49
6.5
5.4
1.91
1.96
mu/l
0.35
364
3193
121
842
1.60
4.42
3.3
3.0
2.46
2.45
mmol/l
0.25
106
755
145
1056
1.55
4.34
3.2
2.9
345.55
347.37
umol/l
0.06
128
917
105
710
1.63
4.30
3.8
3.0
0.91
1.09
e6/l
0.15
49
379
417
3866
2.17
4.23
37.0
20.1
139.49
139.68
mmol/l
0.88
412
3792
24
97
2.56
4.20
2.5
3.2
1.46
1.86
index
0.15
13
63
417
3870
2.16
4.15
37.5
20.3
3.96
3.99
mmol/l
1.02
412
3790
98
657
1.63
4.15
3.9
3.2
3.02
2.05
e6/l
0.32
43
326
128
918
1.55
4.07
1.9
1.7
0.96
1.38
mg/l
2.09
99
737
32
151
2.21
4.01
2.5
1.9
467.85
300.16
ug/l
0.31
32
143
127
912
1.55
4.01
1.4
1.3
0.54
1.33
u/ml
2.70
32
247
84
546
1.66
4.00
2.2
1.9
—
—
—
0
0
334
2951
1.52
3.62
5.0
4.3
14.70
14.90
pmol/l
0.75
314
2664
103
722
1.55
3.58
2.4
2.0
—
—
—
0
0
14
46
3.11
3.56
1.3
1.3
—
—
—
0
0
40
216
1.94
3.54
1.7
1.3
—
—
—
0
0
253
2127
1.44
3.48
4.4
3.9
0.00
3.49
estimate
0.50
49
465
201
1621
1.44
3.47
4.5
4.0
35.22
37.31
ng/l
0.11
136
1207
250
2104
1.43
3.37
4.4
3.9
0.00
0.00
estimate
0.50
46
453
8
14
5.80
3.35
2.9
3.3
0.57
0.59
mmol/l
—
8
14
24
111
2.23
3.18
1.1
1.2
—
—
—
0
0
76
513
1.58
3.10
2.3
2.0
—
—
—
0
0
252
2145
1.40
3.07
4.4
4.0
0.00
0.71
estimate
0.50
49
429
170
1354
1.41
3.05
4.3
3.5
82.42
51.65
e6/l
0.23
130
1039
65
428
1.61
2.94
1.9
1.6
1.84
1.52
%
0.98
50
363
14
52
2.75
2.91
1.7
1.4
—
—
—
0
0
16
64
2.56
2.90
1.3
1.4
—
—
—
0
0
14
53
2.69
2.82
1.7
1.4
—
—
—
0
0
14
53
2.69
2.82
1.7
1.4
—
—
—
0
0
170
1372
1.39
2.76
3.4
3.2
1328.16
1343.37
ng/l
0.02
140
1175
52
332
1.64
2.67
3.1
2.8
59.91
65.00
ml/min/173m2
0.43
23
137
23
113
2.09
2.66
1.1
1.2
—
—
—
0
0
43
261
1.72
2.66
1.9
1.7
—
—
—
0
0
18
82
2.25
2.51
5.8
6.9
3905.40
454.69
iu/ml
—
5
13
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
24
123
2.01
2.50
4.3
2.5
0.23
0.34
iu/ml
1.77
11
67
99
742
1.43
2.43
1.4
1.3
26.72
30.89
iu/ml
0.13
39
240
24
125
1.97
2.40
1.6
3.6
6.90
2.39
ratio
0.34
12
71
423
4045
1.85
2.31
46.1
25.7
252.74
246.74
e9/l
0.93
418
3967
423
4045
1.85
2.31
46.1
25.7
4.37
4.48
e12/l
4.31
416
3954
13
53
2.50
2.29
1.8
1.4
—
—
—
0
0
121
951
1.37
2.25
3.1
2.8
5.68
4.73
e6/l
0.29
112
865
23
123
1.92
2.15
1.2
1.4
—
—
—
0
0
416
3969
1.69
2.15
18.8
12.6
25.42
25.51
u/l
0.05
405
3850
13
55
2.40
2.14
1.8
1.4
—
—
—
0
0
13
55
2.40
2.14
1.8
1.4
—
—
—
0
0
392
3692
1.50
2.13
6.3
5.4
6.02
6.00
mmol/l
0.07
365
3367
7
20
3.54
2.06
1.9
2.3
—
—
—
0
0
80
597
1.41
2.01
1.6
1.5
—
—
—
0
0
24
134
1.84
1.99
1.8
1.9
—
—
—
0
0
331
3041
1.34
1.98
40.2
22.2
329.76
331.83
g/l
3.51
331
3026
30
180
1.71
1.97
1.3
1.4
—
—
—
0
0
6
16
3.79
1.94
1.0
2.8
534.33
731.69
u/ml
—
6
16
58
414
1.46
1.85
4.2
3.6
—
—
—
0
0
49
340
1.50
1.80
8.4
4.2
1.23
1.23
mmol/l
0.35
42
297
20
109
1.87
1.80
1.6
1.7
—
—
—
0
0
50
350
1.48
1.77
2.0
2.5
6.28
8.03
ug/l
0.36
44
310
20
110
1.86
1.76
1.5
1.9
—
—
—
0
0
26
156
1.71
1.73
2.7
3.0
—
—
—
0
0
87
676
1.36
1.72
1.3
1.3
26.45
10.29
u/ml
0.70
36
271
20
111
1.84
1.71
1.6
1.3
—
—
—
0
0
105
842
1.32
1.69
2.0
1.8
448.91
15643715.85
pmol/l
0.80
87
684
23
135
1.74
1.66
1.7
1.3
—
—
—
0
0
7
25
2.83
1.65
2.0
1.5
25.43
30.50
umol/l
—
7
20
36
240
1.54
1.60
4.4
3.3
3.02
2.12
mmol/l
0.59
29
179
243
2179
1.25
1.57
3.2
2.8
—
—
—
0
0
27
169
1.64
1.56
1.9
1.5
0.41
0.32
mg/l
0.32
13
70
18
101
1.81
1.51
1.1
1.3
—
—
—
0
0
29
187
1.59
1.50
1.2
1.1
—
—
—
0
0
9
38
2.40
1.46
1.7
1.2
—
—
—
0
0
21
125
1.71
1.46
1.3
1.2
—
—
—
0
0
18
103
1.78
1.43
1.5
1.4
—
—
—
0
0
5
18
2.80
1.29
1.4
1.3
—
—
—
0
0
164
1433
1.23
1.28
3.6
3.4
7.00
7.49
mmol/l
0.84
143
1202
378
3611
1.30
1.23
7.5
6.9
39.59
39.76
mmol/mol
0.13
346
3368
17
101
1.71
1.21
2.9
2.2
111.17
127.77
g/l
1.88
12
78
181
1605
1.21
1.21
4.2
3.9
0.00
0.03
estimate
1.55
44
376
8
38
2.12
1.19
1.0
1.3
—
—
—
0
0
8
38
2.12
1.19
1.3
1.4
324.13
554.64
u/l
—
8
38
6
128
0.46
1.18
3.0
1.8
34.50
40.87
nmol/l
—
6
121
17
102
1.69
1.18
1.5
1.2
—
—
—
0
0
10
50
2.02
1.17
4.0
4.0
—
—
—
0
0
5
20
2.52
1.15
1.8
1.7
47.58
54.98
ug/l
—
5
20
5
20
2.52
1.15
1.0
1.1
—
—
—
0
0
8
41
1.97
1.09
1.1
1.1
—
—
—
0
0
135
1174
1.21
1.09
3.4
3.4
0.02
0.08
estimate
0.38
43
369
30
213
1.44
1.05
5.0
3.1
18.78
90.53
u/ml
0.74
30
207
18
114
1.60
1.04
1.8
1.5
—
—
—
0
0
381
3662
1.27
1.03
27.5
16.7
78.44
78.48
ml/min/173m2
0.01
363
3406
9
47
1.93
1.02
1.1
1.1
—
—
—
0
0
19
123
1.57
1.01
1.5
1.6
—
—
—
0
0
159
1414
1.19
1.00
4.5
4.2
6.54
8.90
mg/mmol
0.61
106
872
107
917
1.22
0.99
4.3
4.2
1.02
1.02
kg/l
0.68
76
629
371
3560
1.25
0.98
4.6
4.5
1.28
1.28
mmol/l
0.03
336
3237
7
37
1.91
0.94
1.1
1.1
—
—
—
0
0
7
37
1.91
0.94
1.1
1.1
—
—
—
0
0
7
37
1.91
0.94
1.1
1.1
—
—
—
0
0
6
27
2.24
0.94
3.0
1.8
223.83
194.19
e6/l
—
6
21
13
78
1.69
0.92
1.2
1.7
—
—
—
0
0
64
525
1.26
0.89
1.7
1.5
—
—
—
0
0
16
103
1.57
0.88
1.7
1.7
5.47
4.36
iu/l
—
7
40
17
112
1.54
0.86
1.2
1.2
—
—
—
0
0
182
1657
1.17
0.85
2.1
2.0
1.34
1.35
mmol/l
0.04
151
1370
8
47
1.71
0.81
1.1
1.9
—
—
—
0
0
10
58
1.74
0.80
1.2
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
24
0.00
0.79
0.0
1.2
—
—
—
0
0
5
24
2.10
0.74
2.0
1.7
—
—
—
0
0
9
56
1.62
0.72
1.1
1.1
—
1.34
—
0
9
383
3717
1.21
0.71
5.4
5.3
1.42
1.47
mmol/l
1.41
349
3412
13
85
1.55
0.69
1.7
1.6
—
—
—
0
0
19
259
0.72
0.67
1.6
1.9
3.44
3.47
mmol/l
0.07
11
198
7
44
1.60
0.65
1.3
1.6
—
—
—
0
0
7
44
1.60
0.65
1.3
1.6
—
—
—
0
0
7
44
1.60
0.65
1.3
1.6
—
—
—
0
0
384
3735
1.20
0.65
5.5
5.4
4.47
4.59
mmol/l
1.55
352
3446
5
29
1.73
0.64
2.2
1.7
558.60
503.25
e6/l
—
5
20
5
30
1.67
0.61
1.2
1.2
—
—
—
0
0
5
30
1.67
0.61
1.2
1.2
—
—
—
0
0
8
50
1.61
0.61
1.1
1.8
—
—
—
0
0
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
0
21
0.00
0.60
0.0
1.3
—
7.38
—
0
21
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
8
53
1.52
0.58
2.4
1.9
—
—
—
0
0
15
106
1.43
0.58
1.2
1.2
—
1.00
—
0
8
6
35
1.72
0.58
1.2
1.1
—
—
—
0
0
28
349
0.79
0.55
2.1
2.1
3.77
3.45
ratio
0.77
20
288
9
62
1.46
0.53
1.1
1.5
—
—
—
0
0
6
39
1.55
0.53
1.2
1.1
1.32
1.90
nmol/l
—
6
34
16
117
1.38
0.53
1.4
1.6
—
—
—
0
0
388
3793
1.17
0.52
6.5
6.2
2.60
2.66
mmol/l
0.76
357
3487
11
75
1.48
0.51
1.6
1.3
—
—
—
0
0
60
524
1.17
0.49
5.4
5.1
33.74
31.96
%
0.80
43
332
19
146
1.31
0.47
1.4
1.3
31.41
26.20
iu/l
0.27
14
125
13
94
1.39
0.46
10.2
3.4
15.25
9.27
pmol/l
0.71
13
94
5
31
1.62
0.43
1.6
1.1
—
—
—
0
0
10
139
0.71
0.42
1.5
1.8
4.28
4.17
mg/l
—
10
109
5
33
1.52
0.41
1.0
1.5
—
—
—
0
0
5
33
1.52
0.41
1.4
1.5
—
62.00
—
0
5
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
7
102
0.68
0.40
2.6
1.8
148.00
222.84
pmol/l
—
7
94
7
101
0.69
0.40
1.0
1.1
1.34
1.57
g/l
—
7
101
10
71
1.42
0.39
1.6
1.6
—
—
—
0
0
5
35
1.43
0.39
1.0
1.1
—
—
—
0
0
16
124
1.30
0.39
1.2
1.2
—
2.72
—
0
17
0
19
0.00
0.39
0.0
1.1
—
—
—
0
0
13
98
1.34
0.38
1.2
1.3
—
—
—
0
0
16
125
1.29
0.37
1.2
1.2
—
2.57
—
0
26
14
111
1.27
0.30
1.5
1.5
—
—
—
0
0
10
76
1.32
0.28
1.8
1.2
—
—
—
0
0
76
819
0.91
0.27
2.8
3.2
0.54
0.78
ug/l
3.17
53
542
31
274
1.14
0.25
2.3
1.9
—
—
—
0
0
5
38
1.32
0.23
8.2
2.3
—
—
—
0
0
5
41
1.22
0.22
1.4
1.1
—
—
—
0
0
5
41
1.22
0.22
1.0
1.1
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
12
0.00
0.21
0.0
1.1
—
—
—
0
0
0
12
0.00
0.21
0.0
2.1
—
2.37
—
0
6
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
5
43
1.16
0.21
1.0
1.1
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
126
1209
1.06
0.19
4.7
4.0
0.00
0.01
estimate
0.74
46
425
12
101
1.19
0.16
1.7
1.5
—
—
—
0
0
133
1376
0.95
0.16
5.3
5.6
1.39
2.62
ug/l
3.48
117
1227
12
102
1.18
0.15
3.1
2.6
38.71
109.45
ug/min
—
7
60
9
107
0.84
0.13
2.3
1.7
—
—
—
0
0
9
108
0.83
0.13
1.3
1.2
0.99
0.89
g/l
—
9
108
51
483
1.06
0.12
8.3
6.9
—
—
—
0
0
11
95
1.16
0.11
1.4
1.2
—
49.38
—
0
13
27
251
1.08
0.10
2.1
1.8
—
—
—
0
0
10
87
1.15
0.09
1.4
1.5
—
—
—
0
0
6
55
1.09
0.09
1.0
1.0
—
—
—
0
0
11
98
1.13
0.07
1.1
1.4
1.45
14.73
e6/l
1.00
11
71
9
100
0.90
0.06
1.8
1.4
—
—
—
0
0
23
243
0.94
0.05
1.3
1.2
125.52
129.67
u/ml
—
9
100
11
100
1.10
0.05
1.1
1.4
6.55
1333.68
e6/l
0.59
11
75
109
1103
0.98
0.03
4.1
4.6
22.12
21.39
%
0.17
50
540
15
147
1.02
0.00
2.4
1.6
—
—
—
0
0
10
98
1.02
0.00
1.1
1.4
3.68
3.82
mmol/l
—
10
91
16
158
1.01
0.00
2.5
1.8
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
1.18
—
0
5
5
53
0.94
-0.00
1.2
1.5
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
27.31
—
0
8
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.6
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.7
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
6
61
0.98
-0.00
1.2
1.1
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
57
0.88
-0.00
1.4
1.3
0.55
0.35
nmol/l
—
5
42
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_OESOPHAGUS and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_OESOPHAGUS | 1.743 [1.42, 2.14] | < 0.001 |
| Birth year | 0.998 [0.99, 1.01] | 0.605 |
During the follow-up period (1.1.1998 — 31.12.2019), 220 out of 904 females with CD2_BENIGN_OESOPHAGUS died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_OESOPHAGUS | 2.397 [1.96, 2.94] | < 0.001 |
| Birth year | 0.986 [0.98, 1.0] | 0.005 |
During the follow-up period (1.1.1998 — 31.12.2019), 354 out of 951 males with CD2_BENIGN_OESOPHAGUS died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_OESOPHAGUS.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.182% | 0.547% |
| 5 | 1.21% | 2.914% |
| 10 | 2.852% | 6.638% |
| 15 | 5.388% | 13.23% |
| 20 | 9.566% | 20.951% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_OESOPHAGUS – Benign neoplasm: Oesophagus
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data